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Abstract
High-dimensional mass and flow cytometry (HDCyto) experiments have
become a method of choice for high-throughput interrogation and
characterization of cell populations. Here, we present an updated R-based
pipeline for differential analyses of HDCyto data, largely based on
Bioconductor packages. We computationally define cell populations using
FlowSOM clustering, and facilitate an optional but reproducible strategy for
manual merging of algorithm-generated clusters. Our workflow offers
different analysis paths, including association of cell type abundance with a
phenotype or changes in signalling markers within specific subpopulations,
or differential analyses of aggregated signals. Importantly, the differential
analyses we show are based on regression frameworks where the HDCyto
data is the response; thus, we are able to model arbitrary experimental
designs, such as those with batch effects, paired designs and so on. In
particular, we apply generalized linear mixed models or linear mixed
models to analyses of cell population abundance or cell-population-specific
analyses of signaling markers, allowing overdispersion in cell count or
aggregated signals across samples to be appropriately modeled. To
support the formal statistical analyses, we encourage exploratory data
analysis at every step, including quality control (e.g., multi-dimensional
scaling plots), reporting of clustering results (dimensionality reduction,
heatmaps with dendrograms) and differential analyses (e.g., plots of
aggregated signals).
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Introduction
Flow cytometry and the more recently introduced CyTOF (cytometry by time-of-flight mass spectrometry or 
mass cytometry) are high-throughput technologies that measure protein abundance on the surface or within cells. 
In flow cytometry, antibodies are labeled with fluorescent dyes and fluorescence intensity is measured using lasers 
and photodetectors. CyTOF utilizes antibodies tagged with metal isotopes from the lanthanide series, which have 
favorable chemistry and do not occur in biological systems; abundances per cell are recorded with a time-of-flight 
mass spectrometer. In either case, fluorescence intensities (flow cytometry) or ion counts (mass cytometry) are 
assumed to be proportional to the expression level of the antibody-targeted antigens of interest.
Due to the differences in acquisition, further distinct characteristics should be noted. Conventional fluorophore-
based flow cytometry is non-destructive and can be used to sort cells for further analysis. However, because of 
the spectral overlap between fluorophores, compensation of the data needs to be performed1, which also limits the 
number of parameters that can be measured simultaneously. Thus, standard flow cytometry experiments measure 
6–12 parameters with modern systems measuring up to 20 channels2, while new developments (e.g., BD FACSym-
phony) promise to increase this capacity towards 50. Moreover, flow cytometry offers the highest throughput with 
tens of thousands of cells measured per second at relatively low operating costs per sample.
By using rare metal isotopes in CyTOF, cell autofluorescence can be avoided and spectral overlap is drastically 
reduced. However, the sensitivity of mass spectrometry results in the measurement of metal impurities and oxide 
formations, which need to be carefully considered in antibody panel design (e.g., through antibody concentrations and 
coupling of antibodies to neighboring metals). Leipold et al. recently commented that minimal spillover does not 
equal no spillover3. Nonetheless, CyTOF offers a high dimension of parameters measured per cell, with current pan-
els using ~40 parameters and the promise of up to 100. Throughput of CyTOF is lower, at the rate of hundreds of 
cells per second, and cells are destroyed during ionization.
The ability of flow cytometry and mass cytometry to analyze individual cells at high-throughput scales has 
resulted in a wide range of biological and medical applications. For example, immunophenotyping assays are used 
to detect and quantify cell populations of interest, to uncover new cell populations and compare abundance of 
cell populations between different conditions, for example between patient groups4. Thus, it can be used as a 
biomarker discovery tool.
Various methodological approaches aim for biomarker discovery5. A common strategy, which we will refer to through-
out this workflow as the “classic” approach, is to first identify cell populations of interest by manual gating or auto-
mated clustering6,7. Second, using statistical tests, one can determine which of the cell subpopulations or protein 
markers are associated with a phenotype (e.g., clinical outcome) of interest. Typically, cell subpopulation abun-
dance expressed as cluster cell counts or median marker expression would be used in the statistical model to 
relate to the sample-level phenotype.
Importantly, there are many alternatives to what we propose below, and several methods have emerged. For instance, 
Citrus8 tackles the differential discovery problem by strong over-clustering of the cells, and by building a hierar-
chy of clusters from very specific to general ones. Using model selection and regularization techniques, clus-
ters and markers that associate with the outcome are identified. A further machine learning approach, CellCnn9, 
learns the representation of clusters that are associated with the considered phenotype by means of convolutional 
neural networks, which makes it particularly applicable to detecting discriminating rare cell populations. Another 
approach, cydar10 performs differential abundance analysis on “hypersphere” counts, where hyperspheres are 
defined using all markers, and calculates differential tests using the the generalized linear modeling capabilities 
of edgeR11.
            Amendments from Version 3
CATALYST now takes advantage of Bioconductor’s infrastructure for single cell data types (i.e., the 
SingleCellExperiment class), thereby simplifying organization, access, and manipulation of data objects; this 
greatly facilitates interaction with other Bioconductor packages (e.g., scater) for dimensionality reduction and 
visualization. This necessarily changed some of the commands to prepare data and run dimensionality reduction 
approaches. Other than the text to describe the main container objects (formerly using daFrame, now using 
SingleCellExperiment objects), all text and figures have remained the same. 
Any further responses from the reviewers can be found at the end of the article
REVISED
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However, there are tradeoffs to consider. Citrus performs feature selection but does not provide significance lev-
els, such as p-values, for the strength of associations. Due to its computational requirements, Citrus cannot be run 
on entire mass cytometry datasets and one typically must analyze a subset of the data. The “filters” from CellCnn 
may identify one or more cell subsets that distinguish experimental groups, while these groups may not neces-
sarily correspond to any of the canonical cell types, since they are learned with a data-driven approach. Since the 
hyperspheres from cydar are defined using all markers, interpretation of differential expression of specific markers 
(e.g., functional markers) within cell populations is difficult.
A noticeable distinction between the machine-learning approaches and our classical regression approach is 
the configuration of the model. Citrus and CellCnn model the patient response as a function of the measured 
HDCyto values, whereas the classical approach models the HDCyto data itself as the response, thus putting the 
distributional assumptions on the experimental HDCyto data. This carries the distinct advantage that covariates 
(e.g., age, gender, batch) can be included, together with finding associations of the phenotype to the predic-
tors of interest (e.g., cell type abundance). Specifically, neither Citrus nor CellCnn are able to directly account for 
covariates, such as paired experiments or presence of batches. Another recent approach, mixed-effects association 
testing for single cells (MASC) uses the same “reverse” association approach that we illustrate below12. Recently, 
we have formalized and compared various regression approaches, resulting in the diffcyt package13.
Within the classical approach, hybrid methods are certainly possible, where discovery of interesting cell popu-
lations is done with one algorithm, and quantifications or signal aggregations are modeled in standard regression 
frameworks. For instance, CellCnn provides p-values from a t-test or Mann-Whitney U-test conducted on the 
frequencies of previously detected cell populations. Some caution is warranted here, in terms of using data twice – 
so-called double dipping or circular analysis – and making claims about the statistical evidence of a change in 
abundance where initial analyses of the same data were used to discover subpopulations. This topic has been 
discussed with respect to clustering other types of single cell data and then inferring the markers of such 
populations14; however, it is less clear how much clustering affects cross-sample inferences.
Step by step, this workflow presents differential discovery analyses assembled from a suite of tools and methods 
that, in our view, lead to a higher level of flexibility and robust, statistically-supported and interpretable results. 
Cell population identification is conducted by means of unsupervised clustering using the FlowSOM and 
ConsensusClusterPlus packages, which together were among the best performing clustering approaches for 
high-dimensional cytometry data15. Notably, FlowSOM scales easily to millions of cells and thus no subsetting 
of the data is required.
To be able to analyze arbitrary experimental designs (e.g., batch effects, paired experiments, etc.), we show how 
to conduct differential analysis of cell population abundances using generalized linear mixed models (GLMM) 
and of marker intensities using linear models (LM) and linear mixed models (LMM). For both differential 
abundance and expression analysis, we use methods implemented in the diffcyt package13. Internally, model fitting 
is performed with packages lme4 and stats, and hypothesis testing with the multcomp package.
For visualization, we use new plotting functions from the CATALYST package that employ ggplot2 as their graphi-
cal engine. Notably, CATALYST delivers a suite of useful visual representations of HDCyto data characteristics, such 
as an MDS (multidimensional scaling) plot of aggregated signal for exploring sample similarities. The obtained 
cell populations are visualized using dimension reduction techniques (e.g., UMAP via the umap package) and 
heatmaps (via the ComplexHeatmap package16) to represent characteristics of the annotated cell populations and 
identified biomarkers. (Note that an alternative R implementation of the UMAP algorithm with additional 
functionality is also available in the uwot package.)
The workflow is intentionally not fully automatic. First, we strongly advocate for exploratory data analysis to 
get an understanding of data characteristics before formal statistical modeling. Second, the workflow involves an 
optional step where the user can manually merge and annotate clusters (see Cluster merging and annotation section) 
but in a way that is easily reproducible. The CyTOF data used here (see Data description section) is already pre-
processed; i.e., the normalization and de-barcoding, as well as removal of doublets, debris and dead cells, were 
already performed; further details are available in the Data preprocessing section.
Notably, this workflow is equally applicable to flow or mass cytometry datasets, for which the preprocessing steps 
have already been performed. In addition, the workflow is modular and can be adapted as new algorithms or new 
knowledge about how to best use existing tools comes to light. Alternative clustering algorithms such as the popular 
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PhenoGraph algorithm17 (e.g., via the Rphenograph package), dimensionality reduction techniques, such as diffu-
sion maps18 via the destiny package19, t-SNE via the Rtsne and SIMLR20 via the SIMLR package could be inserted 
into the workflow.
Note: To cite this workflow, please refer to this F1000 article https://f1000research.com/articles/6-748.
Reproducibility
To generate reproducible results, we set random seeds in several steps of the workflow. However, the default 
methods for random number generation in R were updated in R version 3.6.0 (released in April 2019; see R News 
for details). Therefore, for consistency with earlier versions of the workflow, we use the function RNGversion() 
to use the random number generation methods from the previous version of R. Note that this step is not required 
when running a standard analysis on a new dataset; it is included here for reproducibility and backward 
compatibility only.
RNGversion("3.5.3")
Data description
We use a subset of CyTOF data originating from Bodenmiller et al.21 that was also used in the Citrus paper8. In 
the original study, peripheral blood mononuclear cells (PBMCs) in unstimulated and after 11 different stimu-
lation conditions were measured for 8 healthy donors. For each sample, expression of 10 cell surface markers 
and 14 signaling markers was recorded. We perform our analysis on samples from the reference and one 
stimulated condition where cells were crosslinked for 30 minutes with B cell receptor/Fc receptor known as 
BCR/FcR-XL, resulting in 16 samples in total (8 patients, unstimulated and stimulated for each).
The original data is available from the Cytobank report. The subset used here can be downloaded from the Citrus 
Cytobank repository (files with _BCR-XL.fcs or _Reference.fcs endings) or from the HDCytoData22 
package via Bodenmiller_BCR_XL_flowSet() (see Data import section).
In both the Bodenmiller et al. and Citrus manuscripts, the 10 lineage markers were used to identify cell subpopula-
tions. These were then investigated for differences between reference and stimulated cell subpopulations separately 
for each of the 14 functional markers. The same strategy is used in this workflow; 10 lineage markers are used for cell 
clustering and 14 functional markers are tested for differential expression between the reference and 
BCR/FcR-XL stimulation. Even though differential analysis of cell abundance was not in the scope of the 
Bodenmiller et al. experiment, we present it here to highlight the generality of the discovery.
Data preprocessing
Conventional flow cytometers and mass cytometers produce .fcs files that can be manually analyzed using pro-
grams such as FlowJo [TriStar] or Cytobank23, or using R/Bioconductor packages, such as flowWorkspace24 and 
openCyto25. During this initial analysis step, dead cells are removed, compensation is checked and with simple 
two dimensional scatter plots (e.g., marker intensity versus time), marker expression patterns are checked. Often, 
modern experiments are barcoded in order to remove analytical biases due to individual sample variation or 
acquisition time. Preprocessing steps including normalization using bead standards26, de-barcoding27 and compen-
sation can be completed with the CATALYST package28, which also provides a Shiny app for interactive analysis. 
Of course, preprocessing steps can occur using custom scripts within R or outside of R (e.g., Normalizer26).
Data import
We recommend as standard practice to keep an independent record of all samples collected, with additional infor-
mation about the experimental condition, including sample or patient identifiers, processing batch and so on. 
That is, we recommend having a trail of metadata for each experiment. In our example, the metadata file, 
PBMC8_metadata.xlsx, can be downloaded from the Robinson Lab server with the download.file() 
function. For the workflow, the user should place it in the current working directory (getwd()). Here, we load it 
into R with the read_excel() function from the readxl package and save it into a variable called md, but 
other file types and interfaces to read them in are also possible.
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The data frame md contains the following columns:
•	 file_name with names of the .fcs files corresponding to the reference (suffix “Reference”) and 
BCR/FcR-XL stimulation (suffix “BCR-XL”) samples,
•	 sample_id with shorter unique names for each sample containing information about conditions and 
patient IDs. These will be used to label samples throughout the entire workflow.
•	 condition describes whether samples originate from the reference (Ref) or stimulated (BCRXL) 
condition,
•	 patient_id defines the IDs of patients.
library(readxl)                                                
url <- "http://imlspenticton.uzh.ch/robinson_lab/cytofWorkflow"
md <- "PBMC8_metadata.xlsx"                                    
download.file(file.path(url, md), destfile = md, mode = "wb")  
md <- read_excel(md)                                           
head(data.frame(md))                                           
##                            file_name sample_id condition patient_id
## 1    PBMC8_30min_patient1_BCR-XL.fcs    BCRXL1     BCRXL   Patient1
## 2 PBMC8_30min_patient1_Reference.fcs      Ref1       Ref   Patient1
## 3    PBMC8_30min_patient2_BCR-XL.fcs    BCRXL2     BCRXL   Patient2
## 4 PBMC8_30min_patient2_Reference.fcs      Ref2       Ref   Patient2
## 5    PBMC8_30min_patient3_BCR-XL.fcs    BCRXL3     BCRXL   Patient3
## 6 PBMC8_30min_patient3_Reference.fcs      Ref3       Ref   Patient3
In our example, the data from the .fcs files listed in the metadata can be loaded from the HDCytoData package22.
library(HDCytoData)                                                       
fs <- Bodenmiller_BCR_XL_flowSet()                                         
Alternatively, the files can be downloaded manually from the Citrus Cytobank repository and loaded into R 
as a flowSet using read.flowSet() from the flowCore package29. Importantly, read.flowSet() and the 
underlying read.FCS() functions, by default, may transform the marker intensities and remove cells with extreme 
positive values. This behavior can be controlled with arguments transformation and truncate_max_range, 
respectively.
In our example, information about the panel is also available in a file called PBMC8_panel.xlsx, and can be 
downloaded from the Robinson Lab server and loaded into a variable called panel. It contains columns for 
Isotope and Metal that define the atomic mass number and the symbol of the chemical element conjugated 
to the antibody, respectively, and Antigen, which specifies the protein marker that was targeted; two additional 
columns specify whether a channel belongs to the lineage or functional type of marker.
The isotope, metal and antigen information that the instrument receives is also stored in the flowFrame 
(container for one sample) or flowSet (container for multiple samples) objects. One can type fs[[1]] to see 
the first flowFrame, which contains a table with columns name and desc. Their content can be retrieved with 
accessors pData(parameters(fs[[1]])). The variable name corresponds to the column names in the 
flowSet object, and can be viewed in R via colnames(fs).
It should be checked that elements from panel can be matched to their corresponding entries in the flowSet object. 
Specifically, the entries in panel$Antigen must have an equivalent in the desc columns of the flowFrame 
objects. In the following analysis, we will often use marker IDs as column names in the tables containing expres-
sion values. As a cautionary note, during object conversion from one type to another (e.g., in the creation of 
data.frame from a matrix), some characters (e.g., dashes) in the dimension names are replaced with dots, which 
may cause problems in matching. To avoid this problem, we will replace problematic characters (dashes with 
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underscores; colons with dots) when organizing all data (measurement data, panel, and experimental metadata) 
into a SingleCellExperiment (SCE) object (see below).
panel <- "PBMC8_panel_v3.xlsx"                                     
download.file(file.path(url, panel), destfile = panel, mode = "wb")
panel <- read_excel(panel)                                         
head(data.frame(panel))                                            
##      fcs_colname antigen marker_class
## 1 CD3(110:114)Dd     CD3         type
## 2  CD45(In115)Dd    CD45         type
## 3 pNFkB(Nd142)Dd   pNFkB        state
## 4  pp38(Nd144)Dd    pp38        state
## 5   CD4(Nd145)Dd     CD4         type
## 6  CD20(Sm147)Dd    CD20         type
# spot check that all panel columns are in the flowSet object
all(panel$fcs_colname %in% colnames(fs))                                     
## [1] TRUE
Data transformation
Usually, the raw marker intensities read by a cytometer have strongly skewed distributions with varying 
ranges of expression, thus making it difficult to distinguish between the negative and positive cell populations. 
It is common practice to transform CyTOF marker intensities using, for example, arcsinh (inverse hyperbolic sine) 
with cofactor 58,30 to make the distributions more symmetric and to map them to a comparable range of expression, 
which is important for clustering. A cofactor of 150 has been promoted for flow cytometry, but users are free to 
implement alternative transformations, some of which are available from the transform() function of the 
flowCore package. By default, the prepData() SCE constructor (see next section) arcsinh transforms marker 
expressions with a cofactor of 5.
As the ranges of marker intensities can vary substantially, for visualization, we apply another transformation that 
scales the expression of all markers to values between 0 and 1 using low (e.g., 1%) and high (e.g., 99%) per-
centiles as the boundary. This additional transformation of the arcsinh-transformed data can sometimes give 
better visual representation of relative differences in marker expression between annotated cell populations. How-
ever, all computations (differential testing, hierarchical clustering etc.) are still performed on arcsinh-transformed 
not scaled expressions. Whether scaled expression values should be plotted is specified with argument scale = 
TRUE or FALSE in the respective visualizations (e.g., plotExprHeatmap() and plotClusterHeatmap()).
Data organization
We will store all data used and returned throughout differential analysis in an object of the SingleCellExperi-
ment (SCE) class. For this, CATALYST provides the wrapper prepData() to construct a SCE object from the 
following inputs:
•	 x: a flowSet containing the raw measurement data, or a character string that specifies the path to a set of 
.fcs files.
•	 panel: a data.frame containing, for each marker, i) its column name in the input raw data, ii) its 
targeted protein markers, and, optionally, iii) its class (type, state, or none).
•	 md: a data.frame with columns describing the experimental design.
Argument features specifies which columns (channels) to retain from the input data. By default, all 
measurement parameters will be kept (features = NULL). Here, we only keep the channels listed in panel.
It is important to carefully check whether variables are of the desired type (factor, numeric, character), since 
input methods may convert columns into different data types. This is taken care of by the prepData() SCE con-
structor. For the statistical modeling, we want to make the condition variable a factor with the reference (Ref) 
being the reference level. The order of factor levels can be defined with the levels parameter of the factor 
function or via relevel().
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As a final note, prepData() requires the filenames listed in the md$file_name column to match those in the 
flowSet.
# specify levels for conditions & sample IDs to assure desired ordering 
md$condition <- factor(md$condition, levels = c("Ref", "BCRXL"))        
md$sample_id <- factor(md$sample_id,                                    
    levels = md$sample_id[order(md$condition)])                         
                                                                        
# construct SingleCellExperiment                                        
sce <- prepData(fs, panel, md, features = panel$fcs_colname)            
Diagnostic plots
We propose some quick checks to verify whether the data we analyze globally represents what we expect; for 
example, whether samples that are replicates of one condition are more similar and are distinct from samples 
from another condition. Another important check is to verify that marker expression distributions do not have any 
abnormalities such as having different ranges or distinct distributions for a subset of the samples. This could high-
light problems with the sample collection or data acquisition, or batch effects that were unexpected. Depending on 
the situation, one can then consider removing problematic markers or samples from further analysis; in the 
case of batch effects, a covariate column could be added to the metadata table and used below in the statistical 
analyses.
The step below generates a plot with per-sample marker expression distributions, colored by condition 
(Figure 1). Here, we can already see distinguishing markers, such as pNFkB and CD20, between stimulated and 
unstimulated conditions.
p <- plotExprs(sce, color_by = "condition")
p$facet$params$ncol <- 6                   
p                                          
Figure 1. Per-sample smoothed densities of marker expression (arcsinh-transformed) of 10 lineage markers and 
14  functional markers  in  the PBMC dataset. Two conditions: unstimulated (Ref) and stimulated with BCR/FcR-XL 
(BCRXL) for each of the 8 healthy donors are presented and colored by experimental condition.
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Another spot check is the number of cells per sample (Figure 2). This plot can be used as a guide together with 
other readouts to identify samples where not enough cells were assayed. The number of cells measured in each 
sample is also stored in the experiment_info slot of the SingleCellExperiment’s metadata, and can 
be accessed directly via n_cells().
n_cells(sce) # or, equivalently, `metadata(sce)$experiment_info$n_cells`
##  BCRXL1     Ref1     BCRXL2    Ref2    BCRXL3    Ref3   BCRXL4   Ref4   BCRXL5    Ref5
##    2838     2739      16675   16725     12252    9434     8990   6906     8543   11962
## BCRXL6    Ref6    BCRXL7   Ref7   BCRXL8    Ref8
##   8622   11038      14770  15974    11653   13670
plotCounts(sce, color_by = "condition")
MDS plot
In transcriptomics applications, one of the most utilized exploratory plots is the multi-dimensional scal-
ing (MDS) plot or a principal component analysis (PCA) plot. Such plots show similarities between samples 
measured in an unsupervised way and give a sense of how much differential expression can be detected before 
conducting any formal tests. In transcriptomics, distances between samples are calculated based on the expres-
sion of the top varying genes. We propose a similar plot for HDCyto data using median marker expression over all 
cells to calculate dissimilarities between samples (other aggregations are also possible, and one could reduce the 
number of top varying markers to include in the calculation). Ideally, samples should cluster well within the same 
condition, although this depends on the magnitude of the difference between experimental conditions. With this 
diagnostic, one can identify outlier samples and eliminate them if the circumstances warrant it. An MDS plot on 
the median marker expressions can be generated with plotMDS(), which internally calls the same-named limma 
function.
In our MDS plot on median marker expression values (Figure 3), we can also see that the first dimension (MDS1) 
separates the unstimulated and stimulated samples reasonably well. The second dimension (MDS2) represents, to 
some degree, differences between patients. Most of the samples that originate from the same patient are placed at 
Figure 2. Barplot showing the number of cells measured for each sample in the PBMC dataset. Bars are colored 
by experimental condition: unstimulated (Ref) and stimulated with BCR/FcR-XL (BCRXL). Numbers in the names on the 
x-axis indicate patient IDs. Numbers on top of the bars indicate the cell counts.
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Figure 3. MDS plot for the unstimulated (Ref) and stimulated with BCR/FcR-XL (BCRXL) samples obtained for each 
of the 8 healthy donors in the PBMC dataset. Calculations are based on the median (arcsinh-transformed) marker 
expression of 10 lineage markers and 14 functional markers across all cells measured for each sample. Distances 
between samples in the plot approximate the typical change in medians. Numbers in the label names indicate patient 
IDs.
a similar point along the y-axis, for example, samples from patients 7, 5, and 8 are at the bottom of the plot, 
while samples from patient 4 are located at the top of the plot. This also indicates that the marker expression of 
individual patients is driving similarity and perhaps should be formally accounted for in the downstream 
statistical modeling.
CATALYST::plotMDS(sce, color_by = "condition")
In contrast to genomic applications, the number of variables measured for each sample is much lower in HDCyto 
data. In the former, thousands of genes are surveyed, whereas in the latter, ~20-50 antigens are typically tar-
geted. Similar to the MDS plot above, a heatmap of the same data also gives insight into the structure of the data. 
The heatmap shows median marker intensities with clustered columns (markers) and rows (samples). We have 
used hierarchical clustering with average linkage and Euclidean distance, but also Ward’s linkage could be used8, 
and in CyTOF applications, a cosine distance shows good performance31. In this plot, we can see which markers 
drive the observed clustering of samples (Figure 4).
As with the MDS plot, the dendrogram separates the reference and stimulated samples very well. Also, similar 
groupings of patients within experimental conditions are observed.
plotExprHeatmap(sce, bin_anno = TRUE, row_anno = TRUE)
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Figure  4.  Heatmap  of  the  median  (arcsinh-transformed)  marker  expression  of  10  lineage  markers  and  14 
functional markers across all cells measured for each sample in the PBMC dataset. Color-coded with yellow for 
lower expression and blue for higher expression. The numbers in the heatmap represent the actual expression values. 
Dendrograms present clustering of samples (rows) and markers (columns) which is based on hierarchical clustering 
with Euclidean distance metric and average linkage. Row annotations on the left of the heatmap represent the two 
conditions: unstimulated (Ref) and stimulated with BCR/FcR-XL (BCRXL), and patient IDs for each of the 8 healthy 
donors.
Marker ranking based on the non-redundancy score
In this step, we identify the ability of markers to explain the variance observed in each sample. In particular, we 
calculate the PCA-based non-redundancy score (NRS)17. Markers with higher score explain a larger portion of 
variability present in a given sample.
The average NRS can be used to select a subset of markers that are non-redundant in each sample but at the same 
time capture the overall diversity between samples. Such a subset of markers can then be used for cell popula-
tion identification analysis (i.e., clustering). We note that there is no precise rule on how to choose the right cutoff 
for marker inclusion, but one option is to select a suitable number of the top-scoring markers. The number can be 
chosen by analyzing the plot with the NR scores (Figure 5), where the markers are sorted by the decreasing aver-
age NRS. Based on prior biological knowledge, one can refine the marker selection and remove markers that are not 
likely to distinguish cell populations of interest, even if they have high scores, and add in markers with low scores 
but known to be important in discerning cell subgroups17. Thus, the NRS analysis serves more as a guide to marker 
selection and is not meant as a hard rule.
In the dataset considered here8,21, we want to use all the 10 lineage markers, so there is no explicit need 
to restrict the set of cell surface markers, and the NRS serve as another quality control step. There may be other 
situations where this feature selection step would be of interest, for example, in panel design17.
plotNRS(sce, features = type_markers(sce), color_by = "condition")
Cell population identification with FlowSOM and ConsensusClusterPlus
Cell population identification typically has been carried out by manual gating, a method based on visual inspec-
tion of a series of two-dimensional scatterplots. At each step, a subset of cells, either positive or negative for 
the two visualized markers, is selected and further stratified in the subsequent iterations until populations of 
Page 11 of 55
F1000Research 2019, 6:748 Last updated: 15 JAN 2020
Figure 5. Non-redundancy scores for each of the 10 lineage markers and all samples in the PBMC dataset. The full 
points represent the per-sample NR scores (colored by experimental conditions), while empty black circles indicate the 
mean NR scores from all the samples. Markers on the x-axis are sorted according to the decreasing average NRS.
interest across a range of marker combinations are captured. However, manual gating has drawbacks, such as 
subjectivity, bias toward well-known cell types, and inefficiency when analyzing large datasets, which also 
contribute to a lack of reproducibility5.
Considerable effort has been made to improve and automate cell population identification, such as unsupervised 
clustering32. However, not all methods scale well in terms of performance and speed from the lower dimensionality 
flow cytometry data to the higher dimensionality mass cytometry data15, since clustering in higher dimensions 
can suffer the “curse of dimensionality”.
Beside the mathematical and algorithmic challenges of clustering, cell population identification may be dif-
ficult due to the chemical and biological aspects of the cytometry experiment itself. Therefore, caution should be 
taken when designing panels aimed at detecting rare cell populations by assigning higher sensitivity metals to 
rare markers. The right choice of a marker panel used for clustering can also be important. For example, it should 
include all markers that are relevant for cell type identification.
In this workflow, we conduct cell clustering with FlowSOM33 and ConsensusClusterPlus34, which appeared 
amongst the fastest and best performing clustering approaches in a recent study of HDCyto datasets15. This ensem-
ble showed strong performance in detecting both high and low frequency cell populations and is one of the fastest 
methods to run, which enables its interactive usage. We use a slight modification of the original workflow 
presented in the FlowSOM vignette, which we find more flexible. In particular, we directly call the 
ConsensusClusterPlus() function that is embedded in metaClustering_consensus(). 
Thus, we are able to access all the functionality of the ConsensusClusterPlus package to explore the number of 
clusters.
The FlowSOM workflow consists of three steps: i) building a self-organizing map (SOM), where cells are 
assigned according to their similarities to 100 (by default) grid points (or, so-called codebook vectors or codes) of 
the SOM; ii) building a minimal spanning tree, which is mainly used for graphical representation of the clusters, 
is skipped in this pipeline; and iii) metaclustering of the SOM codes, is performed with the ConsensusClusterPlus 
package. These are wrapped in the CATALYST function cluster(). Additionally, we add an optional 
round of manual expert-based merging of the metaclusters and allow this to be done in a reproducible fashion.
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It is important to point out that we cluster all cells from all samples together. This strategy is beneficial, since 
we directly obtain cluster assignment for each cell, we label cell populations only once and the mapping of 
cell types between samples is automatically consistent. For a list of alternative approaches and their advantages 
and disadvantages, please refer to the Discussion section, where we consider: clustering per sample, clustering of 
data from different measurement batches and down-sampling in case of widely varying numbers of cells per sample.
CATALYST provides the wrapper function cluster() to perform both FlowSOM clustering and 
Consensus-ClusterPlus metaclustering. The clustering IDs obtained after the first high-dimensional clustering step 
are added to the input SCE’s colData in the cluster_id column. The cluster codes for the lower dimen-
sional metaclusterings to 2 through maxK clusters are stored as list element cluster_codes in the metadata. 
In this way, all levels of clustering are computed once and kept accessible for further investigation, visualization, 
and differential analysis.
The subset of markers to use for clustering is specified with argument features. For future reference, the specified 
markers will be assigned class "type", and the remainder of markers will be assigned to be "state" markers. 
The sets of type and state markers can be accessed at any point with the type_markers() and state_ 
markers() accessor functions, respectively.
In our example, we have specified marker classes in the input panel, and cluster() will default to using 
"type" markers for clustering. For clarity, we specify this explicitly via features = type_markers(sce). 
We call ConsensusClusterPlus() with maximum number of clusters maxK = 20.
FlowSOM output can be sensitive to random starts15. To make results reproducible, we first set a seed for ran-
dom number generation prior to calling cluster(), and, secondly, specifcy a seed argument inside 
cluster(). Unfortunately, this is necessary as the ConsensusClusterPlus() function internally 
calls set.seed() and will, when not provided with a seed, overwrite our seed using the current system time 
(set.seed(as.numeric(Sys.time()))).
In general, it is advisable to rerun analyses with multiple random seeds, for two reasons. First, one can see how 
robust the detected clusters are, and second, when the goal is to find smaller cell populations, it may happen that, in 
some runs, random starting points do not represent rare cell populations, as the chance of selecting starting 
cells from them is low and they are merged into a larger cluster.
set.seed(1234)
sce <- cluster(sce, features = type_markers(sce),    
    xdim = 10, ydim = 10, maxK = 20, seed = 1234)    
Automatic approaches for selecting the number of clusters in HDCyto data do not always succeed15. In gen-
eral, we therefore recommend some level of over-clustering, and if desired, manual merging of clusters. Such a 
hierarchical approach is especially suited when the goal is to detect smaller cell populations.
The SPADE clustering analysis performed by Bodenmiller et al.21 identified 6 main cell types (T-cells, mono-
cytes, dendritic cells, B-cells, NK cells and surface- cells) that were further stratified into 14 more specific sub-
populations (CD4+ T-cells, CD8+ T-cells, CD14+ HLA-DR high monocytes, CD14+ HLA-DR med monocytes, 
CD14+ HLA-DR low monocytes, CD14- HLA-DR high monocytes, CD14- HLA-DR med monocytes, CD14- 
HLA-DR low monocytes, dendritic cells, IgM+ B-cells, IgM- B-cells, NK cells, surface- CD14+ cells and 
surface- CD14- cells). In our analysis, we are interested in identifying the 6 main PBMC populations, including: 
CD4+ T-cells, CD8+ T-cells, monocytes, dendritic cells, NK cells and B-cells. Following the concept of over-cluster-
ing, we perform the metaclustering of the (by default) 100 SOM codes into more than expected number of groups. 
For example, stratification into 20 groups should give enough resolution to detect these main clusters. We can 
explore the clustering in a wide variety of visualizations: UMAP plots, heatmaps and the “delta area” from 
ConsensusClusterPlus.
When the interest is in studying more specific subpopulations at higher detail, one can follow a strategy of 
reclustering as described in the Obtaining higher resolution section, where we propose to repeat the workflow 
(clustering and differential analyses) after gating out a selected subpopulation (e.g., one of the large populations).
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We can then investigate characteristics of identified clusters with heatmaps that illustrate median marker expres-
sion in each cluster (Figure 6). As the range of marker expression can vary substantially from marker to marker, 
we use the 0-1 transformed data for some visualizations (argument scale = TRUE in the respective plot-
ting functions). However, to stay consistent with FlowSOM and ConsensusClusterPlus, we use the (arcsinh- 
transformed) unscaled data to generate the dendrogram of the hierarchical structure of metaclusters.
Instead of using only medians, which do not give a full representation of cluster specifics, one can plot the entire 
marker expression distribution in each cluster (Figure 7). Such a plot gives more detailed profile of each cluster, 
but represents a larger amount of information to interpret. Heatmaps give an overall overview of clusters, are 
quicker and easier to interpret, and together with the dendrogram can be a good basis for further cluster merging 
(see Cluster merging and annotation section).
plotClusterHeatmap(sce,                               
    hm2 = NULL, k = "meta20", m = NULL,               
    cluster_anno = TRUE, draw_freqs = TRUE)           
                   
plotClusterExprs(sce, k = "meta20", features = "type")  
In addition to investigating expression of the lineage markers, we can also have a look at expression of the func-
tional markers. We propose a heatmap that depicts median expression of functional markers in each sample 
(Figure 8) such that the potential differential expression can be investigated already at this data exploration step 
before the formal testing is done. In order to plot all the heatmaps in one panel, we use the ComplexHeatmap 
package16.
plotClusterHeatmap(sce, hm2 = "pS6", k = "meta20", draw_freqs = TRUE)
Figure 6. Heatmap of  the median marker  intensities of  the 10  lineage markers across the 20 cell populations 
obtained with FlowSOM after the metaclustering step with ConsensusClusterPlus (PBMC data). The color in the 
heatmap represents the median of the arcsinh, 0-1 transformed marker expression calculated over cells from all the 
samples, varying from blue for lower expression to red for higher expression. The dendrogram on the left represents 
the hierarchical similarity between the 20 metaclusters (metric: Euclidean distance; linkage: average). Each cluster has 
a unique color assigned (bar on the left) which is identical in other visualizations of these 20 clusters (e.g., the UMAP 
shown in Figure 10) facilitating the figure interpretation. Barplot along the rows (clusters) and values in brackets on the 
right indicate the relative sizes of clusters.
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Figure  7.  Distributions  of  marker  intensities  (arcsinh-transformed)  of  the  10  lineage  markers  in  the  20  cell 
populations obtained with FlowSOM after the metaclustering step with ConsensusClusterPlus (PBMC data). Red 
densities represent marker expression for cells in a given cluster. Blue densities are calculated over all the cells and 
serve as a reference.
Visual representation with UMAP
One of the most popular plots for representing single cell data are t-SNE plots, where each cell is represented in 
a lower, usually two-dimensional, space computed using t-stochastic neighbor embedding (t-SNE)35,36. More gen-
erally, dimensionality reduction techniques represent the similarity of points in 2 or 3 dimensions, such that 
similar objects in high-dimensional space are also similar in lower dimensional space. Mathematically, there 
are a myriad of ways to define this similarity. For example, principal component analysis (PCA) uses linear 
combinations of the original features to find orthogonal dimensions that show the highest levels of variability; 
the top 2 or 3 principal components can then be visualized.
Nevertheless, there are a few notes of caution when using t-SNE or any other dimensionality reduction technique. 
Since they are based on preserving similarities between cells, those that are similar in the original space will 
be close in the 2D/3D representation, but the opposite does not always hold. In our experience, t-SNE with 
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Figure 8. Heatmap of the median marker intensities of the 10 lineage markers and one signaling marker (pS6) 
across the 20 cell populations obtained with FlowSOM after the metaclustering step with ConsensusClusterPlus 
(PBMC data). The left panel presents a heatmap analogous to the one in Figure 6. Heatmap on the right represents 
the median of the arcsinh, 0-1 transformed marker expression for a signaling marker pS6 calculated over cells in each 
sample (columns) individually.
default parameters for HDCyto data is often suitable (for more guidance on the specifics of t-SNE, see How to Use 
t-SNE Effectively37).
Another nonlinear dimensionality reduction technique, uniform manifold approximation and projection (UMAP), 
has recently been directly compared to t-SNE, and shown to outperform t-SNE in runtime, reproducibil-
ity, and its ability to organize cells into meaningful clusters38,39. Throughout this workflow, we use UMAP as our 
dimensionality reduction method of choice, but other techniques, such as PCA, diffusion maps19, SIMLR20, iso-
maps or t-SNE could be applied. Alternative algorithms, such as largeVis40 (available via the largeVis package) or 
hierarchical stochastic neighbor embedding (HSNE)41, can also be used for dimensionality reduction of very large 
datasets without downsampling. Alternatively, the dimensionality reduction can be performed on the codes of 
the SOM, at a resolution (size of the SOM) specified by the user (Figure 13).
A variety of dimension reduction methods are available in the scater package and can be run via runX(), 
where X = "PCA", "TSNE", "UMAP", "MDS" or "DiffusionMap" (see ?"scater-red-dim-args" 
for details). To make results reproducible, the random seed should be set via set.seed prior to dimen-
sion reduction. The assay containing expression values (default logcounts) should be specified via argument 
exprs_values, and the subset of markers to use for computing reduced dimensions is specified via 
subset_row. Here, we will use the set of type-markers accessible via type_markers(sce).
Most dimensionality reduction techniques require significant computational time to process the data. To keep run-
ning times reasonable for larger CyTOF datasets, one may use a subset of cells. Here, we first split the vector 
of cell indices by sample ID and sample at most 500 cells per sample for dimension reduction.
# run t-SNE/UMAP on at most 500/1000 cells per sample                     
set.seed(1234)                                                            
sce <- runDR(sce, dr = "TSNE", cells = 500, features = "type")            
sce <- runDR(sce, dr = "UMAP", cells = 1e3, features = "type")            
Page 16 of 55
F1000Research 2019, 6:748 Last updated: 15 JAN 2020
The UMAP map below is colored according to the expression level of the CD4 marker, highlighting the posi-
tion of CD4+ T-cells (Figure 9). In this way, one can use a set of markers to highlight where cell types of interest 
are located on the map. If one is loosely interpreting density of points in the map, it is recommended to 
select a fixed number of cells per sample.
plotDR(sce, "UMAP", color_by = "CD4")
Alternatively, we can color the cells by any resolution of clustering available in the codes. Here, we compare 
the t-SNE and UMAP projections of cells colored by the 20 metaclusters. Ideally, cells of the same color should 
be close to each other (Figure 10). When the plots are further stratified by sample (Figure 11), we can verify 
whether similar cell populations are present in all replicates, which can help in identifying outlying samples. Option-
ally, stratification can be done by condition (Figure 12). With such a spot-check plot, we can inspect whether dif-
ferences in cell abundance are strong between conditions, and we can visualize and identify distinguishing 
clusters before applying formal statistical testing. A similar approach of data exploration was proposed in studies 
of treatment-specific differences of polyfunctional antigen-specific T-cells42.
Figure 9. UMAP based on the arcsinh-transformed expression of the 10 lineage markers in the cells from the 
PBMC dataset. UMAP was run with no PCA step. From each of the 16 samples, 1000 cells were randomly selected. 
Cells are colored according to the expression level of the CD4 marker.
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Figure 10. t-SNE and UMAP based on the arcsinh-transformed expression of the 10 lineage markers in the cells 
from the PBMC dataset. From each of the 16 samples, 500 (t-SNE) and 1000 (UMAP) cells were randomly selected. 
Cells are colored according to the 20 cell populations obtained with FlowSOM after the metaclustering step with 
ConsensusClusterPlus.
Figure 11. UMAP as in Figure 10, but stratified by sample.
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Figure 12. UMAP as in Figure 10, but stratified by condition.
Figure  13. The 100 SOM codes in the PBMC dataset colored according to the metaclustering with 
ConsensusClusterPlus into 20 cell populations presented after the dimension reduction with (A) t-SNE and (B) PCA. The 
SOM codes represent characteristics of the 100 (by default) clusters generated in the first step of the FlowSOM pipeline. 
The size of the points corresponds to the number of cells that were assigned to a given code.
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p1 <- plotDR(sce, "TSNE", color_by = "meta20") +                              
    theme(legend.position = "none")                                           
p2 <- plotDR(sce, "UMAP", color_by = "meta20")                                
lgd <- get_legend(p2 +                                                        
    guides(color =  guide_legend(ncol = 2, override.aes = list(size = 3))))   
p2 <- p2 + theme(legend.position = "none")                                    
plot_grid(p1, p2, lgd, nrow = 1, rel_widths = c(5, 5, 2))                     
## Facet per sample                                                           
plotDR(sce, "UMAP", color_by = "meta20")  + facet_wrap("sample_id") +         
    guides(color = guide_legend(ncol = 2, override.aes = list(size = 3)))
## Facet per condition                                       
plotDR(sce, "UMAP", color_by = "meta20") + facet_wrap("condition") +           
    guides(color = guide_legend(ncol = 2, override.aes = list(size = 3)))
The SOM codes represent characteristics of the 100 (by default) clusters generated in the first step of the Flow-
SOM pipeline. Their visualization can also be helpful in understanding the cell population structure and deter-
mining the number of clusters. Ultimately, the metaclustering step uses the codes and not the original cells. 
We treat the codes as new representative cells and apply the t-SNE dimension reduction to visualize them in 2D 
(Figure 13). The size of the points corresponds to the number of cells that were assigned to a given code. The 
points are colored according to the results of metaclustering. Since we have only 100 data points, the t-SNE 
analysis is fast.
As there are multiple ways to mathematically define similarity in high-dimensional space, it is always good prac-
tice visualizing projections from other methods to see how consistent the observed patterns are. For instance, 
we also represent the FlowSOM codes via the first two principal components (Figure 13).
plotCodes(sce, k = "meta20")
Using heatmaps, we can also visualize median marker expression in the 100 SOM codes as in Figure 14. Of 
note, the clustering presented with the dendrogram does not completely agree with the clustering depicted by the 
20 colors because the first one is based on the hierarchical clustering with average linkage and Euclidean distance, 
while the second one results from the consensus clustering.
plotClusterHeatmap(sce,                     
    hm2 = "pS6", k = "som100", m = "meta20",
    cluster_anno = FALSE, draw_freqs = TRUE)
Cluster merging and annotation
In our experience, manual merging of clusters leads to slightly different results compared to an algorithm with a 
specified number of clusters. In order to detect somewhat rare populations, some level of over-clustering is necessary 
so that the more subtle populations become separated from the main populations. In addition, merging can 
always follow an over-clustering step, but splitting of existing clusters is not generally feasible.
In our setup, over-clustering is also useful when the interest is identifying the “natural” number of clusters 
present in the data. In addition to heatmaps and UMAP plots, one could investigate the delta area plot from the 
ConsensusClusterPlus package and the hierarchical clustering dendrogram of the over-clustered subpopulations, 
as shown in Figure 16 and Figure 18.
In our example, we expect around 6 specific cell types, and we have performed FlowSOM clustering into 20 groups 
as a reasonable over-estimate. After analyzing the heatmaps (Figure 6) and UMAP plots (Figure 10), we can clearly 
see that stratification of the data into 20 clusters may be too strong. In the UMAP plot, many clusters are placed 
very close to each other, indicating that they could be merged together. The same can be deduced from the heat-
maps, highlighting that marker expression patterns for some neighboring clusters are very similar. Cluster merging 
and annotation is somewhat manual, based partially on visual inspection of UMAP plots and heatmaps and thus, 
benefits from expert knowledge of the cell types.
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Figure 14. Heatmap of the median marker intensities of the 10 lineage markers (left panel) and one signaling marker 
pS6 (right panel) across the 100 SOM codes in the PBMC dataset. The color in the heatmap represents the median 
of the arcsinh, 0-1 transformed marker expression calculated over cells from all the samples, for the lineage markers, 
and over cells in each sample individually, for the signaling marker. The heat varies from blue for lower expression to red 
for higher expression. The dendrogram on the left represents the hierarchical similarity between the 100 codes (metric: 
Euclidean distance; linkage: average). The annotation bar on the left is colored according to the code metaclustering 
with ConsensusClusterPlus into 20 cell populations. The relative size of the codes is shown in parentheses next to the 
cluster numbers.
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Manual cluster merging and annotation based on heatmaps. Our main reference for manual merging of clus-
ters is the heatmap of marker characteristics across metaclusters (e.g., Figure 6), with dendrograms showing the 
hierarchy of similarities. Such plots show cluster- or cluster-sample level information, and thus aggregate marker 
expression across many cells. Together with dimensionality reduction, these plots give good insight into the rela-
tionships between clusters and the marker levels within each cluster. Given expert knowledge of the cell types and 
markers, it is then left to the researcher to decide how exactly to merge clusters (e.g., with higher weight given 
to some markers).
The dendrogram highlights the similarity between the metaclusters and can be used explicitly for the merg-
ing. However, there are reasons why we would not always follow the dendrogram exactly. In general, when it 
comes to clustering, blindly following the hierarchy of codes will lead to identification of populations of similar 
cells, but it does not necessarily mean that they are of biological interest. The distances between metaclusters are 
calculated across all the markers, and it may be that some markers carry higher weight for certain cell types. In 
addition, different linkage methods may lead to a different hierarchy, especially when clusters are not fully 
distinct. Another aspect to consider in cluster merging is the cluster size, represented in the parentheses next to the 
cluster label in our plots. If the cluster size is very small, but the cluster seems relevant and distinct, one can keep it 
as separate. However, if it is small and different from the neighboring clustering only in a somewhat unimportant 
marker, it could be merged. And, if some of the metaclusters do not represent any specific cell types, they could 
be dropped out of the downstream analysis instead of being merged. However, in case an automated solution 
for cluster merging is truly needed, one could use the cutree() function applied to the dendrogram.
Based on the set random seed, a manual merging of the 20 metaclusters is defined in PBMC8_cluster_ 
merging1.xlsx available at the Robinson Lab server. This merging table contains, for each of the origi-
nal clusters, an ID to newly assign to cells assigned to the given cluster. Clusters may be merged with the 
mergeClusters() function from CATALYST. For future reference, each manual merging is assigned an ID 
specified with argument id. Note that, if multiple old clusters are given the same new label, the respective clusters 
will be merged.
In this example, our expert has annotated 8 cell populations: CD8 T-cells, CD4 T-cells, B-cells IgM-, B-cells 
IgM+, NK cells, dendritic cells (DCs), monocytes and surface negative cells; monocytes could be further 
subdivided based on HLA-DR into high, medium and low subtypes.
merging_table1 <- "PBMC8_cluster_merging1.xlsx"       
download.file(file.path(url, merging_table1),         
    destfile = merging_table1, mode = "wb")           
merging_table1 <- read_excel(merging_table1)          
head(data.frame(merging_table1))                      
##   original_cluster  new_cluster
## 1                1 B-cells IgM+
## 2                2     surface-
## 3                3     NK cells
## 4                4  CD8 T-cells
## 5                5 B-cells IgM-
## 6                6    monocytes
# convert to factor with merged clusters in desired order                
merging_table1$new_cluster <- factor(merging_table1$new_cluster,         
    levels = c("B-cells IgM+", "B-cells IgM-", "CD4 T-cells",            
        "CD8 T-cells", "DC", "NK cells", "monocytes", "surface-"))        
                                                                         
# apply manual merging                                                   
sce <- mergeClusters(sce, k = "meta20",                                  
    table = merging_table1, id = "merging1")                             
We can view the UMAP plot with the new annotated cell populations by specifying color_by = "merging1" 
(Figure 15).
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Figure 15. UMAP plot  for  the PBMC dataset, where cells are colored according to the manual merging of  the 
20 cell populations, obtained with FlowSOM, into 8 PBMC populations. As in Figure 10, UMAP uses the arcsinh-
transformed expression of the 10 lineage markers in 1000 randomly selected cells from each of the 16 samples.
plotDR(sce, "UMAP", color_by = "merging1")
One of the useful representations of merging is a heatmap of median marker expression in each of the original clus-
ters, which are labeled according to the proposed merging, Figure 16. As before, the clustering to use for computing 
cluster medians is specified with k = "meta20". For visualization, we can specify a second layer of cluster 
annotations with m = "merging1".
plotClusterHeatmap(sce, k = "meta20", m = "merging1")
To get a final summary of the annotated cell types, we can plot a heatmap of median marker expressions that are calcu-
lated based on the manual merging’s cluster annotations (Figure 17).
plotClusterHeatmap(sce, k = "merging1")
Reducing the number of clusters in ConsensusClusterPlus. The ConsensusClusterPlus package provides visu-
alizations that can help to understand the metaclustering process and the characteristics of the analyzed data. For 
example, the delta area plot (Figure 18) highlights the amount of extra cluster stability gained when clustering into k 
groups as compared to k-1 groups (from k=2 to k=20). It can be expected that high stability of clusters can be 
reached when clustering into the number of groups that best fits the data. Thus, using the delta area plot could help 
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Figure 16. Heatmap as in Figure 6, where the additional color bar on the left indicates how the 20 metaclusters, 
obtained with FlowSOM, are merged into the 8 PBMC populations.
finding the “natural” number of clusters present in the data, which would correspond to the value of k where there 
is no appreciable increase in stability. This strategy can be referred as the “elbow criterion”. For more details 
about the meaning of this plot, the user can refer to the original description of the consensus clustering method43.
The elbow criterion is quite subjective since the “appreciable” increase is not defined exactly. For example, in the 
delta plot below, we could say that the last point before plateau is for k=6, or for k=5, or for k=3, depending on 
our perception of sufficient decrease of the delta area score. Moreover, the exact point where a plateau is reached 
may vary for runs with different random seeds, the drop may not always be so sharp and the function is not 
guaranteed to be decreasing. It is advisable to investigate more of these plots and the resulting UMAP and 
heatmaps before drawing any conclusions about the final number of “natural” clusters.
Manual merging of up to 20 clusters can be laborious. To simplify this task, one could reduce the strength of 
over-clustering and allow the metaclustering method to do a part of the merging, which then can be completed 
manually. Analyzing the delta plot from the right side, we can see how much we can reduce the strength of 
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Figure 17. Heatmap of the median marker intensities of the 10 lineage markers in the 8 PBMC cell populations 
obtained by manual merging of the 20 metaclusters generated by FlowSOM. As in Figure 6, the heat represents the 
median of arcsinh and 0-1 transformed marker expression calculated over cells from all the samples. The dendrogram 
on the left represents the hierarchical similarity between the 8 populations calculated using Euclidean distance and 
average linkage.
Figure 18. The delta area plot generated in the metaclustering step by the ConsensusClusterPlus function. The 
delta area score (y-axis) indicates the relative increase in cluster stability obtained when clustering the 100 SOM codes 
generated by FlowSOM into k groups (x-axis).
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over-clustering while still obtaining stable clusters. In parallel, one should check the heatmaps to see whether the less 
stringent stratification is able to capture cell populations of interest.
As an example, we consider the metaclustering to 12 groups. Clustering into as few as 12 groups still allows us 
to identify the same 8 cell populations as when merging 20 clusters, but these are simpler to define since fewer 
profiles need to be manually scanned. The expert-based merging of the 12 metaclusters into 8 PBMC cell 
populations is saved in the PBMC8_cluster_merging2_v3.xlsx file on the Robinson Lab server.
merging_table2 <- "PBMC8_cluster_merging2_v3.xlsx"     
download.file(file.path(url, merging_table2),          
    destfile = merging_table2, mode = "wb")            
merging_table2 <- read_excel(merging_table2)           
data.frame(merging_table2)                             
##   original_cluster   new_cluster
## 1                1  B-cells IgM+
## 2                2      surface-
## 3                3      NK cells
## 4                4   CD8 T-cells
## 5                5  B-cells IgM-
## 6                6     monocytes
## 7                7   CD8 T-cells
## 8                8     monocytes
## 9                9   CD4 T-cells
## 10              10            DC
## 11              11   CD4 T-cells
## 12              12   CD4 T-cells
# convert to factor with merged clusters in desired order       
merging_table2$new_cluster <- factor(                           
    merging_table2$new_cluster,                                 
    levels = levels(merging_table1$new_cluster))                
                                                                
# apply manual merging                                          
sce <- mergeClusters(sce, k = "meta12",                         
    table = merging_table2, id = "merging2")                    
Comparison of automated and manual merging. The manual merging of 20 (or 12) clusters by an expert resulted 
in identification of 8 cell populations. To highlight the impact of manual merging versus algorithm-defined 
subpopulations, we compare to the results of an automated cluster merging that is set to stratify the data also 
into 8 clusters. Out of interest, we can see which clusters are split by tabulating the cell labels.
# tabular comparison of algorithmic & manual merging             
table(manual = cluster_codes(sce)[cluster_ids(sce), "merging2"], 
    algorithm = cluster_codes(sce)[cluster_ids(sce), "meta8"] )  
##               algorithm
## manual             1     2     3     4     5     6    7    8
##   B-cells IgM+  6651     0     0     0     0     0    0    0
##   B-cells IgM-  3265     0     0     0     0     0    0    0
##   CD4 T-cells      0     0  1203     0  2603 59174    0 1113
##   CD8 T-cells      0     0 32112     0 19038     0    0    0
##   DC               0     0     0     0     0     0 1980    0
##   NK cells         0     0 23315     0     0     0    0    0
##   monocytes        0     0     0 18436     0     0    0    0
##   surface-         0  3901     0     0     0     0    0    0
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In the UMAP plot (Figure 19), we can see that part of the new cell populations (cluster 6, 1, 2, 4 and 7) over-
lap substantially with populations obtained by the means of manual merging (CD4 T-cells, B-cells, surface-, 
monocytes and DC). However, cells that belong to clusters 3 and 5 are subdivided in a different manner according 
Figure 19. UMAP plot with cells colored according to (A) the expert merging of 12 metaclusters obtained with FlowSOM 
into 8 PBMC populations; and (B) the 8 automatically detected with FlowSOM metaclusters.
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to the manual merging. Cluster 1 consists of both B-cells IgM+ and IgM- and is not further subdivided, whereas 
cluster 8 is altogether unidentifiable.
p1 <- plotDR(sce, "UMAP", color_by = "merging2")              
p2 <- plotDR(sce, "UMAP", color_by = "meta8")                 
plot_grid(p1, p2, ncol = 1, align = "v", labels = c("A", "B"))
The brief example above highlights the difference between automatic clustering and manual merging of algo-
rithm-generated clusters in the search for biologically meaningful cell populations. Automated and manual 
merging may give different weight to marker importance and thus result in different populations being detected. 
However, in our view, the manual merging done here in a reproducible fashion results in a more biologically 
meaningful cell stratification.
Differential analysis
For the dataset used in this workflow8,21, we perform three types of analyses that aim to identify subsets of PBMCs 
and signaling markers that respond to BCR/FcR-XL stimulation, by comparing stimulated samples to unstimu-
lated samples. We first describe differential abundance of the defined cell populations, followed by differential 
analysis of marker expression within each cluster. Finally, differential analysis of the overall aggregated marker 
expression could also be of interest.
The PBMC subsets analyzed in this workflow originate from a paired experiment, where samples from 8 patients 
were treated with 12 different stimulation conditions for 30 minutes, together with unstimulated reference samples21. 
This is a natural example where one would choose a mixed model to model the response (abundance or marker 
signal), and patients would be treated as a random effect. In this way, one can formally account for between- 
patient variability, observed to be quite strong in the MDS plot (MDS plot section), and this should give a gain in 
power to detect differences between conditions.
We use the diffcyt package13 to perform the differential analyses. This package includes implementations of vari-
ous methods for differential testing, including linear mixed models. The mixed models methodology uses the 
stats and lme4 packages to fit the fixed and mixed models, respectively, and the multcomp package for hypothesis 
testing.
In all differential analyses here, we want to test for differences between the reference (Ref) and BCR/FcR-XL 
treatment (BCRXL). The fixed model formula is straightforward: ~ condition, where condition indicates 
the treatment group. The corresponding full model design matrix consists of the intercept and dummy variable 
indicating the treated samples. In the presence of covariates (e.g., batch), one can include them in the model 
by using a formula ~ condition + covariate, or if they affect the treatment, a formula with interactions 
~ condition * covariate. When using the diffcyt package, the model formula can be set up in the 
required format using the createFormula() function.
For testing, the mixed models methodology uses the general linear hypotheses function glht() from the 
multcomp package, which allows testing of arbitrary hypotheses using t-tests. In our analysis, the contrast indicates 
a regression coefficient to be tested equal to zero; i.e., that there is no effect of the BCR/FcR-XL treatment. The 
result of the test is a p-value that indicates the probability of observing an as strong (or stronger) difference between 
the two conditions assuming the null hypothesis is true. The linear hypotheses to be tested are specified using 
a contrast matrix, where the number of rows of the contrast matrix equals the number of columns of the design 
matrix. When using the diffcyt package, the contrast matrix can be created in the required format using the 
createContrast() function.
Testing is performed on each cluster and marker separately, resulting in 8 tests for differential abundance (one 
for each merged population), 14 tests for overall differential marker expression analysis and 8 x 14 tests for dif-
ferential marker expression within populations. Thus, to account for the multiple testing correction, we apply the 
Benjamini-Hochberg adjustment to each of them using a false discovery rate (FDR) cutoff of 5%.
FDR_cutoff <- 0.05
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Differential cell population abundance
Differential analysis of cell population abundance compares the proportions of cell types across experimental con-
ditions and aims to highlight populations that are present at different ratios. First, we calculate two tables: one 
that contains cell counts for each sample and population and one with the corresponding proportions of cell types 
by sample. The proportions are used only for plotting, since the statistical modeling takes the cell counts by cluster 
and sample as input.
For each sample, we plot its PBMC cell type composition represented with colored bars, where the size of a given 
stripe reflects the proportion of the corresponding cell type in a given sample (Figure 20).
plotAbundances(sce, k = "merging1", by = "sample_id")
It may be quite hard to see the differences in cluster abundances in the plot above, especially for clusters with very 
low frequency. And, since boxplots cannot represent multimodal distributions, we show boxplots with jittered 
points of the sample-level cluster proportions overlaid (Figure 21). The y-axes are scaled to the range of data plot-
ted for each cluster, to better visualize the differences in frequency of lower abundance clusters. For this experiment, 
it may be interesting to additionally depict the patient information. We do this by plotting a different point shape 
for each patient. Indeed, we can see that often the direction of abundance changes between the two conditions 
are concordant among the patients.
plotAbundances(sce, k = "merging1", by = "cluster_id", shape = "patient_id")
Since our goal is to compare proportions, one could take these values, transform them (e.g., logit) and use them 
as a dependent variable in a linear model. However, this approach does not take into account the uncertainty of 
proportion estimates, which is higher when ratios are calculated for samples with lower total cell counts. A distri-
bution that naturally accounts for such uncertainty is the binomial distribution (i.e., logistic regression), which 
takes the cell counts as input (relative to the total for each sample). Nevertheless, as in genomic data analysis, pure 
logistic regression is not able to capture the overdispersion that is present in HDCyto data. A natural extension to 
model the extra variation is the generalized linear mixed model (GLMM), where the random effect is defined by the 
sample ID (observation-level random effects44,45). Additionally, in our example the patient pairing could be 
Figure  20.  Relative  abundance  of  the  8  PBMC  populations  in  each  sample  (x-axis),  in  the  PBMC  dataset, 
represented with a barplot. The 8 cell populations are a result of manual merging of the 20 FlowSOM metaclusters.
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Figure 21. Relative abundance of the 8 PBMC populations in each sample, in the PBMC dataset, represented with 
boxplots. Values for the two conditions are indicated with different colors: red for the unstimulated (Ref) and blue for 
the stimulated with BCR/FcR-XL (BCRXL) samples. Values for each patient are indicated with different shape. The 8 cell 
populations are a result of manual merging of the 20 FlowSOM metaclusters.
accounted in the model by incorporating a random intercept for each patient. Thus, we present two GLMMs. Both 
of them comprise a random effect defined by the sample ID to model the overdispersion in proportions. The second 
model includes a random effect defined by the patient ID to account for the experiment pairing.
In our model, the blocking variable is patient ID i = 1, ..., n, where n = 8. For each patient, there are ni samples 
measured, and j = 1, ..., ni indicates the sample ID. Here, ni = 2 for all i (one from reference and one from 
BCR/FcR-XL stimulated).
We assume that for a given cell population, the cell counts Yij follow a binomial distribution Yij ∼ Bin(mij, πij), 
where mij is a total number of cells in a sample corresponding to patient i and condition j.
The GLMM with observation-level random effects ξij is defined as follows:
                                                               
1
0 1 0 1( | , , ) ( ),ij ij ij ijE Y logit xβ β ξ β β ξ−= + +
where 2(0, )ij N ξξ σ∼  and xij corresponds to the conditionBCRXL column in the design matrix and indicates 
whether a sample ij belongs to the reference (xij = 0) or treated condition (xij = 1). Since E(Yij|β0, β1, ξij) = πij, the above 
formula can be written as follows:
                                                                         
0 1( ) .ij ij ijlogit xπ β β ξ= + +
The GLMM that furthermore accounts for the patient pairing incorporates additionally a random intercept for 
each patient i:
                                                            
1
0 1 0 1( | , , , ) ( ),ij i ij ij i ijE Y logit xβ β γ ξ β β γ ξ−= + + +
where 2(0, ).i N γγ σ∼
We set up the model formulas and contrast matrix using the createFormula() and createContrast() 
functions from the diffcyt package. These functions create the model formulas and contrast matrix in the required 
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format for the diffcyt testing functions. For more details, see ?createFormula and ?createContrast, 
or refer to the extended documentation in the diffcyt vignette (diffcyt workflow).
ei <- metadata(sce)$experiment_info 
(da_formula1 <- createFormula(ei,                     
    cols_fixed = "condition",      
    cols_random = "sample_id"))    
## $formula
## y ~ condition + (1 | sample_id)
## <environment: 0x1e422a10>
##
## $data
##    condition sample_id
## 1      BCRXL    BCRXL1
## 2        Ref      Ref1
## 3      BCRXL    BCRXL2
## 4        Ref      Ref2
## 5      BCRXL    BCRXL3
## 6        Ref      Ref3
## 7      BCRXL    BCRXL4
## 8        Ref      Ref4
## 9      BCRXL    BCRXL5
## 10       Ref      Ref5
## 11     BCRXL    BCRXL6
## 12       Ref      Ref6
## 13     BCRXL    BCRXL7
## 14       Ref      Ref7
## 15     BCRXL    BCRXL8
## 16       Ref      Ref8
##
## $random_terms
## [1] TRUE
(da_formula2 <- createFormula(ei,               
    cols_fixed = "condition",                   
    cols_random = c("sample_id", "patient_id")))
## $formula
## y ~ condition + (1 | sample_id) + (1 | patient_id)
## <environment: 0x1e29dc20>
##
## $data
##    condition sample_id patient_id
## 1      BCRXL    BCRXL1   Patient1
## 2        Ref      Ref1   Patient1
## 3      BCRXL    BCRXL2   Patient2
## 4        Ref      Ref2   Patient2
## 5      BCRXL    BCRXL3   Patient3
## 6        Ref      Ref3   Patient3
## 7      BCRXL    BCRXL4   Patient4
## 8        Ref      Ref4   Patient4
## 9      BCRXL    BCRXL5   Patient5
## 10       Ref      Ref5   Patient5
## 11     BCRXL    BCRXL6   Patient6
## 12       Ref      Ref6   Patient6
## 13     BCRXL    BCRXL7   Patient7
## 14       Ref      Ref7   Patient7
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## 15     BCRXL    BCRXL8   Patient8
## 16       Ref      Ref8   Patient8
##
## $random_terms
## [1] TRUE
contrast <- createContrast(c(0, 1))
The diffcyt package provides three methods for differential abundance (DA) analyses, and two methods for differ-
ential state (DS) analyses. For an explanation and comparison of the different methods, see 13. Here, we use the 
DA methodology based on mixed models, which is implemented in the method diffcyt-DA-GLMM. This 
method can be selected by providing the arguments method = "DA" and method_DA = "diffcyt- 
DA-GLMM" to the diffcyt() wrapper function (for more details, see ?diffcyt). As our SCE contains 
a total of 22 clusterings (1 high-resolution, 19 consensus mergings, and 2 manual mergings), we also specify 
the clustering of interest via clustering_to_use = "merging1".
da_res1 <- diffcyt(sce,                                            
    formula = da_formula1, contrast = contrast,                    
    analysis_type = "DA", method_DA = "diffcyt-DA-GLMM",           
    clustering_to_use = "merging1", verbose = FALSE)               
da_res2 <- diffcyt(sce,                                            
    formula = da_formula2, contrast = contrast,
    analysis_type = "DA", method_DA = "diffcyt-DA-GLMM",           
    clustering_to_use = "merging1", verbose = FALSE)               
The diffcyt output consists of a list containing several SummarizedExperiment objects. The differential test results 
are stored in the rowData slot of the results object res, and can be accessed using the rowData() accessor 
function from the SummarizedExperiment package. The results include raw p-values (p_val) and adjusted 
p-values (p_adj) for each cluster (for DA tests) or cluster-marker combination (for DS tests), which can be used 
to rank the clusters or cluster-marker combinations by their evidence for differential abundance (DA tests) or 
differential states within cell populations (DS tests).
names(da_res1)
## [1] "res"                           "d_counts"
## [3] "d_medians"                     "d_medians_by_cluster_marker"
## [5] "d_medians_by_sample_marker"
rowData(da_res1$res)
## DataFrame with 8 rows and 3 columns
##                cluster_id                p_val                p_adj
##                  <factor>            <numeric>            <numeric>
## B-cells IgM+ B-cells IgM+   0.0134820784148451   0.0409234214313668
## B-cells IgM- B-cells IgM-  0.00554110817983844   0.0409234214313668
## CD4 T-cells   CD4 T-cells   0.0376717385468528   0.0753434770937056
## CD8 T-cells   CD8 T-cells   0.0153462830367626   0.0409234214313668
## DC                     DC    0.415414183796348    0.476379043464654
## NK cells         NK cells    0.416831663031572    0.476379043464654
## monocytes       monocytes    0.547254574996547    0.547254574996547
## surface-         surface-    0.371991531862702    0.476379043464654
When we count the number of differential findings for both GLMMs specified above, we find that accounting 
for the patient pairing increases the sensitivity to detect differentially abundant cell populations.
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table(rowData(da_res1$res)$p_adj < FDR_cutoff)
##
## FALSE TRUE
##     5    3
table(rowData(da_res2$res)$p_adj < FDR_cutoff)
##
## FALSE TRUE
##     2    6
A summary table displaying the results (raw and adjusted p-values) together with the observed cell population 
proportions by sample can be generated using diffcyt’s topTable() function. For more details, see ?topTable.
topTable(da_res2, show_props = TRUE, format_vals = TRUE, digits = 2)
## DataFrame with 8 rows and 19 columns
##                cluster_id     p_val     p_adj props_Ref1 props_Ref2
##                  <factor> <numeric> <numeric>  <numeric>  <numeric>
## NK cells         NK cells   4.5e-13   3.6e-12       14.3        9.7
## B-cells IgM- B-cells IgM-   2.2e-11   8.8e-11        1.9        1.3
## B-cells IgM+ B-cells IgM+   3.5e-08   9.2e-08        4.8        2.8
## DC                     DC   7.1e-05   0.00014        0.2        0.9
## CD8 T-cells   CD8 T-cells    0.0012    0.0019       23.7       23.8
## CD4 T-cells   CD4 T-cells    0.0019    0.0025       44.7       49.1
## surface-         surface-      0.22      0.26        2.8        2.5
## monocytes       monocytes      0.26      0.26        7.6        9.9
##              props_Ref3 props_Ref4 props_Ref5 props_Ref6 props_Ref7
##               <numeric>  <numeric>  <numeric>  <numeric>  <numeric>
## NK cells           15.1       14.5       10.2        6.7       22.5
## B-cells IgM-        3.3        1.4        2.5        2.3        2.8
## B-cells IgM+        8.3        4.7        4.4        5.7        4.3
## DC                  1.2        1.2        1.6        0.9        0.9
## CD8 T-cells        15.5       17.6         26       25.3       33.5
## CD4 T-cells        39.7       32.4       38.4       47.3       28.2
## surface-              2        1.4        2.3        3.3        2.1
## monocytes          14.9       26.9       14.5        8.5        5.6
##              props_Ref8 props_BCRXL1 props_BCRXL2 props_BCRXL3
##               <numeric>    <numeric>    <numeric>    <numeric>
## NK cells             11         15.6         11.7         16.6
## B-cells IgM-        2.2          1.1            1            2
## B-cells IgM+        3.8          3.9          1.4          4.1
## DC                  0.9          0.2          0.8          1.5
## CD8 T-cells        34.2         46.1         40.9         26.5
## CD4 T-cells        36.9         26.8         35.8         32.3
## surface-            2.4          1.8            2          2.3
## monocytes           8.5          4.5          6.4         14.7
##              props_BCRXL4 props_BCRXL5 props_BCRXL6 props_BCRXL7
##                 <numeric>    <numeric>    <numeric>    <numeric>
## NK cells             18.3         12.6          6.8         25.5
## B-cells IgM-          1.1          1.5          1.2          2.1
## B-cells IgM+          3.8          3.9            4          2.6
## DC                    1.4          2.1          1.4          1.2
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## CD8 T-cells          25.9         28.2         24.6         34.3
## CD4 T-cells          31.8         36.7         44.1         26.8
## surface-              1.9          2.1          2.7          1.8
## monocytes            15.7         12.9         15.2          5.7
##              props_BCRXL8
##                 <numeric>
## NK cells             12.9
## B-cells IgM-          1.7
## B-cells IgM+          2.7
## DC                    1.2
## CD8 T-cells          39.7
## CD4 T-cells          31.5
## surface-              2.4
## monocytes             7.8
We use a heatmap to report the differential cell populations (Figure 22). Proportions are first scaled with the 
arcsine-square-root transformation (as an alternative to logit that cannot be calculated on ratios of zero or one). 
Then, z-score normalization is applied to each population to better highlight the relative differences between 
compared conditions. In addition, the clusters are sorted according to adjusted p-values.
plotDiffHeatmap(sce, da_res2, th = FDR_cutoff, normalize = TRUE, hm1 = FALSE)
Differential analysis of marker expression stratified by cell population
For this part of the analysis, we calculate the median expression of the 14 signaling markers in each cell popula-
tion (merged cluster) and sample. These will be used as the response variable Yij in the linear model (LM) or linear 
Figure 22. DA test results and normalized proportions for PBMC cell populations in BCR/FcR-XL stimulated and 
unstimulated conditions. The heat represents arcsine-square-root transformed cell frequencies that were subsequently 
normalized per cluster (rows) to mean of zero and standard deviation of one. The color of the heat varies from blue 
indicating relative under-representation to orange indicating relative over-representation. Bars at the top of the heatmap 
indicate patient IDs and the condition the samples (columns) belong to: red for the unstimulated (Ref) and brown for the 
stimulated with BCR/FcR-XL (BCRXL) condition. Bar and numbers at the right indicate significant differentially abundant 
clusters (green) and adjusted p-values. Clusters are sorted according to adjusted p-values, so that the cluster at the top 
shows the most significant abundance changes between the two conditions.
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mixed model (LMM), for which we assume that the median marker expression follows a Gaussian distribution 
(on the already arcsinh-transformed scale). Analogous to the model above, the linear model is formulated as follows:
                                                                       
= β + β +0 1 ,ij ij ijY x ε
where ∈ij ∼ N(0, σ 2), and the mixed model includes a random intercept for each patient:
                                                                
= β + β +γ +0 1 ,ij ij i ijY x ε
where 2(0, ).i N γγ σ∼  In the current experiment, we have an intercept (basal level) and a single covariate, xij, which 
is represented as a binary (stimulated/unstimulated) variable. For more complicated designs or batch effects, 
additional columns of a design matrix can be used.
One drawback of summarizing the protein marker intensity with a median over cells is that all the other character-
istics of the distribution, such as bimodality, skewness and variance, are ignored. On the other hand, it results in a 
simple, easy to interpret approach, which in many cases will be able to detect interesting changes. Another issue 
that arises from using a summary statistic is the level of uncertainty, which increases as the number of cells used to 
calculate it decreases. In the statistical modeling, this problem could be partially handled by assigning observation 
weights (number of cells) to each cluster and sample (parameter weights in the lm and lmer functions used 
within the diffcyt testing functions). However, since each cluster is tested separately, these weights do not 
account for the differences in size between clusters.
There might be instances of small cell populations for which no cells are observed in some samples or where 
the number of cells is very low. For clusters absent from a sample (e.g., due to biological variance or insufficient 
sampling), NAs are introduced because no median expression can be calculated; in the case of few cells, the median 
may be quite variable. Thus, we apply a filter to remove clusters with very low counts (by default, clusters are 
kept if they have at least 3 cells in at least half the total number of samples, which is appropriate for a two-group 
comparison with equal numbers of samples per condition).
It is helpful to plot the median expression of all markers in each cluster for each sample colored by condition, 
to get a rough image of how strong the differences might be (Figure 23). We do this by combining boxplots and jitter.
p <- plotMedExprs(sce, k = "merging1", 
  facet = "cluster_id", shape_by = "patient_id")            
p$facet$params$ncol <- 2                                    
p                                                           
To present how accounting for the between patient variability with the mixed model increases sensitivity, we also 
fit a regular linear model. The linear mixed model has a random intercept for each patient.
ds_formula1 <- createFormula(ei, cols_fixed = "condition")
ds_formula2 <- createFormula(ei,                          
    cols_fixed = "condition", cols_random = "patient_id") 
Using diffcyt, we calculate differential tests using method diffcyt-DS-LMM, which implements the DS 
methodology based on mixed models. This method can be selected by providing the arguments method = "DS" 
and method_DS = "diffcyt-DS-LMM" to the diffcyt() wrapper function. The remaining arguments 
are the same as for the DA tests.
By accounting for the patient effect, we detect almost twice as many cases of differential signaling compared 
to the regular linear model.
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Figure  23. Median  (arcsinh-transformed)  expression  of  14  signaling markers  (x-axis)  across  the  8  identified 
PBMC cell populations (individual panels). Values for the two conditions are indicated with different colors: red for the 
unstimulated (Ref) and blue for the stimulated with BCR/FcR-XL (BCRXL) samples. Values for each patient are indicated 
with different shape. The 8 cell populations are a result of manual merging of the 20 FlowSOM metaclusters.
ds_res1 <- diffcyt(sce,                                            
    formula = ds_formula1, contrast = contrast,                    
    analysis_type = "DS", method_DS = "diffcyt-DS-LMM",            
    clustering_to_use = "merging1", verbose = FALSE)               
table(rowData(ds_res1$res)$p_adj < FDR_cutoff)                     
##
## FALSE TRUE
##    68   44
ds_res2 <- diffcyt(sce,                                            
    formula = ds_formula2, contrast = contrast,                    
    analysis_type = "DS", method_DS = "diffcyt-DS-LMM",            
    clustering_to_use = "merging1", verbose = FALSE)               
table(rowData(ds_res2$res)$p_adj < FDR_cutoff)                     
##
## FALSE TRUE
##    28   84
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topTable() is again used to assemble a summary table.
topTable(ds_res2, top_n = 5, order_by = "cluster_id",
    show_meds = TRUE, format_vals = TRUE, digits = 3)
## DataFrame with 5 rows and 20 columns
##                cluster_id marker_id     p_val     p_adj meds_Ref1
##                  <factor>  <factor> <numeric> <numeric> <numeric>
## B-cells IgM+ B-cells IgM+     pNFkB  6.74e-11  3.43e-10     1.964
## B-cells IgM+ B-cells IgM+      pp38    0.0017   0.00355     0.889
## B-cells IgM+ B-cells IgM+    pStat5    0.0348    0.0464    -0.039
## B-cells IgM+ B-cells IgM+      pAkt  6.11e-14  4.56e-13     2.319
## B-cells IgM+ B-cells IgM+    pStat1    0.0714    0.0889    -0.006
##              meds_Ref2 meds_Ref3 meds_Ref4 meds_Ref5 meds_Ref6 meds_Ref7
##              <numeric> <numeric> <numeric> <numeric> <numeric> <numeric>
## B-cells IgM+     1.869     1.773     2.183     1.861     1.953     1.915
## B-cells IgM+     1.113     0.853     0.642     0.126      0.21     0.128
## B-cells IgM+    -0.049    -0.048    -0.024    -0.057    -0.061    -0.054
## B-cells IgM+      2.31     2.269     3.086     1.729     2.024     2.145
## B-cells IgM+     0.064     0.008     0.515    -0.047      0.03    -0.034
##              meds_Ref8 meds_BCRXL1 meds_BCRXL2 meds_BCRXL3 meds_BCRXL4
##              <numeric>   <numeric>   <numeric>   <numeric>   <numeric>
## B-cells IgM+     1.979       1.179        0.88       0.808       1.473
## B-cells IgM+     0.126       0.109      -0.012       0.044       0.245
## B-cells IgM+    -0.053      -0.037      -0.037      -0.029       0.056
## B-cells IgM+     2.603       3.247        2.96       2.951       3.257
## B-cells IgM+     0.191       0.343       0.126       0.242       0.333
##              meds_BCRXL5 meds_BCRXL6 meds_BCRXL7 meds_BCRXL8
##                <numeric>   <numeric>   <numeric>   <numeric>
## B-cells IgM+       1.361       1.725       1.436       1.575
## B-cells IgM+      -0.046       0.083      -0.039      -0.005
## B-cells IgM+      -0.067      -0.015      -0.051      -0.039
## B-cells IgM+       2.382       3.184       2.762       3.144
## B-cells IgM+       -0.01       0.616       -0.05       0.379
We use a heatmap to report the differential signals (Figure 24). Instead of plotting the absolute expression, we 
display the normalized expression, which better highlights the direction of marker changes. In addition, the cluster-
marker combinations are sorted according to adjusted p-value.
plotDiffHeatmap(sce, ds_res2, top_n = 50, order = TRUE,    
    th = FDR_cutoff, normalize = TRUE, hm1 = FALSE)        
Differential analysis of overall marker expression
The analysis of overall expression is analogous to the previous section, except that median marker expression is 
aggregated from all the cells in a given sample. For this, we generate an artificial clustering with all cells assigned 
to a single cluster.
sce <- mergeClusters(sce, k = "meta20", id = "merging_all",            
    table = data.frame(old_cluster = seq_len(20), new_cluster = "all"))
As before, the median expression can be plotted (Figure 25).
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Figure 24. DS test results and normalized expression of signaling markers in PBMC populations in BCR/FcR- 
XL stimulated and unstimulated conditions. The heat represents median (arcsinh-transformed) marker expression 
that was subsequently normalized per cluster-marker combination (rows) to mean of zero and standard deviation of 
one. The color of the heat varies from blue representing relative under-expression to orange representing relative over-
expression. Bars at the top of the heatmap indicate patient IDs and the condition the samples (columns) belong to: 
red for the unstimulated (Ref) and brown for the stimulated with BCR/FcR-XL (BCRXL) condition. Bar and numbers 
at the right indicate significant differential cluster-marker combinations (green) and adjusted p-values. Cluster-marker 
combinations are sorted according to adjusted p-value, so that the cluster-marker combinations at the top show the 
most significant differential signals between the two conditions. Shown are only the top 50 most highly significant cluster-
marker combinations.
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Figure  25. Median  (arcsinh-transformed)  expression  of  14  signaling markers  calculated  from  all  the  cells  in 
a given sample  in  the PBMC dataset. Values for the two conditions are indicated with different colors: red for the 
unstimulated (Ref) and blue for the stimulated with BCR/FcR-XL (BCRXL) samples. Values for each patient are indicated 
with different shape.
p <- plotMedExprs(sce[state_markers(sce), ], shape_by = "patient_id")
p$facet$params$ncol <- 3                                             
p                                                                    
Similar to the analysis above, we identify more markers being differentially expressed with the LMM, which 
accounts for the between patient variability.
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# fit linear model                                                 
ds_res3 <- diffcyt(sce,                                            
    formula = ds_formula1, contrast = contrast,                    
    analysis_type = "DS", method_DS = "diffcyt-DS-LMM",            
    clustering_to_use = "merging_all", verbose = FALSE)            
                                                                   
# fit linear mixed model with patient ID as random effect          
ds_res4 <- diffcyt(sce,                                            
    formula = ds_formula2, contrast = contrast,                    
    analysis_type = "DS", method_DS = "diffcyt-DS-LMM",            
    clustering_to_use = "merging_all", verbose = FALSE)            
                                                                   
table(rowData(ds_res3$res)$p_adj < FDR_cutoff)                     
##
## FALSE TRUE
##     9    5
table(rowData(ds_res4$res)$p_adj < FDR_cutoff)
##
## FALSE TRUE
##     2   12
As before, we create a summary table and heatmap displaying the results (Figure 26).
topTable(ds_res4, top_n = 5, order_by = "p_adj",     
    show_meds = TRUE, format_vals = TRUE, digits = 3)
## DataFrame with 5 rows and 20 columns
##     cluster_id marker_id     p_val     p_adj meds_Ref1 meds_Ref2 meds_Ref3
##       <factor>  <factor> <numeric> <numeric> <numeric> <numeric> <numeric>
## all        all      pBtk         0         0     0.566     0.615     0.323
## all        all    pSlp76  2.22e-09  1.56e-08     0.506     0.582     0.184
## all        all     pNFkB  1.33e-08  6.21e-08     2.392     2.469      2.67
## all        all      pAkt  3.55e-07  1.24e-06     2.416     2.122       2.3
## all        all       pS6   1.4e-06  3.92e-06    -0.055    -0.039    -0.002
##     meds_Ref4 meds_Ref5 meds_Ref6 meds_Ref7 meds_Ref8 meds_BCRXL1
##     <numeric> <numeric> <numeric> <numeric> <numeric>   <numeric>
## all     0.494      0.39     0.471     0.209     0.297      -0.041
## all     0.297     0.358     0.347      0.09     0.133      -0.051
## all      2.94     1.979     2.025      1.98     1.985        1.07
## all     3.273     1.443     1.573      1.68     2.114       3.053
## all     0.138    -0.025    -0.038    -0.032    -0.029       0.102
##     meds_BCRXL2 meds_BCRXL3 meds_BCRXL4 meds_BCRXL5 meds_BCRXL6
##       <numeric>   <numeric>   <numeric>   <numeric>   <numeric>
## all      -0.007      -0.055      -0.016      -0.054      -0.009
## all      -0.058      -0.062      -0.038      -0.071      -0.045
## all        0.52       1.144        1.74       1.143       1.695
## all       2.727       2.876       3.242       1.958       2.607
## all        0.09       0.534       0.373       0.454       0.356
##     meds_BCRXL7 meds_BCRXL8
##       <numeric>   <numeric>
## all       -0.07      -0.051
## all      -0.074      -0.063
## all       1.195       1.245
## all       2.075       2.416
## all       0.193        0.07
plotDiffHeatmap(sce, ds_res4, all = TRUE, hm1 = FALSE)
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Figure 26. DS  test  results and normalized expression of signaling markers calculated over all cells  in PBMC 
populations  in  BCR/FcR-XL  stimulated  and  unstimulated  conditions.  The heat represents median (arcsinh-
transformed) marker expression that was subsequently normalized per marker (rows) to mean of zero and standard 
deviation of one. The color of the heat varies from blue representing relative under-expression to orange representing 
relative over-expression. Bars at the top of the heatmap indicate patient IDs and the condition the samples (columns) 
belong to: red for the unstimulated (Ref) and brown for the stimulated with BCR/FcR-XL (BCRXL) condition. Bar and 
numbers at the right indicate significant differential markers (green) and adjusted p-values. Markers are sorted according 
to adjusted p-value, so that the marker at the top shows the most significant change between the two conditions.
Obtaining higher resolution
In the proposed workflow, we concentrated on identification of the main cell types in PBMCs. Our goal was 
to identify around 6 main cell types. Following the over-clustering strategy, we have chosen to perform the SOM 
clustering into 100 (by default) groups followed by consensus clustering into 20 groups, from which we could 
annotate 8 cell types. These 8 cell types were then used in the differential analysis.
If the number of expected cell types is higher, the user can increase the size of the SOM grid in CATALYST’s 
cluster() function using the xdim and ydim arguments and increase the maximum number of consensus 
clusters via the maxK argument.
One could also use a strategy based on subsequent clustering of identified clusters, which we refer to as recluster-
ing. In the starting step, one uses the presented workflow to identify the main cell types. In the following steps, 
the same clustering workflow is applied individually to the cell populations for which more resolution is desired. 
Restricting to one subpopulation at a time results in easier cluster annotation. The differential analysis can 
be applied to the final clusters in the same way as described in the workflow assuming tables with cell counts 
and median marker expression are available.
The differential analysis could also be conducted on the unmerged (20) consensus clusters and the manual 
annotation could be done at the end.
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Discussion
In this workflow, we have presented a pipeline for diverse differential analyses of HDCyto datasets. First, we 
highlight quality control steps, where aggregate characteristics of the samples are visualized (e.g., an MDS plot), 
allowing for verification of the experimental design, detection of batch effects and outlying samples. Next, cell 
population identification was carried out via clustering, which forms the basis for subsequent differential analy-
ses of cell population abundance, differential marker expression within a population or overall marker expression 
differences. The approaches to differential analyses proposed here are very general and thus able to model com-
plex experimental designs via design matrices, such as factorial experiments, paired experiments or adjustment 
for batch effects. We have presented a range of visualizations that help in understanding the data and reporting 
the results of clustering and differential analyses.
Clustering is one of the most challenging steps in the workflow, and its accuracy is critical to the downstream 
differential analyses. Getting the right resolution of clusters is crucial, since there can be situations where a bio-
logically meaningful cell population may be differentially enriched between conditions, but in an automatic clus-
tering, was combined with another cell population that behaves differently. We have shown that some level of 
over-clustering is convenient for detecting meaningful cell populations, since automatic detection of the number 
of natural clusters is difficult15. However, there are tradeoffs between the resolution of clustering and the labor 
involved in aggregating them to biologically meaningful clusters. Overall, we take an interactive but flexible 
algorithm-guided approach together with subject-area experts to arrive at sensible cell populations. In particular, 
we rely on various visualizations, such as dendrograms, heatmaps, UMAP embeddings or other dimension reduc-
tion techniques to guide us in the process. Alternative strategies could be combined with the statistical inference we 
present, such as over-clustering combined with data-driven aggregation to the optimal resolution.
While we have a good understanding of how computational algorithms recapitulate manual gating in high 
dimensions15, one of the open areas of research remains how to best cluster across samples. The data analyzed 
here8,21 was generated using sample barcoding; this strategy reduces inter-sample variability, since all samples are 
exposed to the same antibody cocktail and measured in a single acquisition27. Thus, the range of marker expression 
for each channel should, in principle, be within a similar range across samples.
In our approach, we aggregated all cells together before clustering. Because of this aggregation, the clustering is 
blind to the sample labels, and thus in principle, does not bias the downstream statistical inferences. Moreover, we 
directly obtain consistent clustering between samples. However, some challenges may arise when there are substantial 
differences in numbers of cells in samples. There is a risk that larger samples may drive the final clustering results. 
A simple solution to this problem could be ensuring that each sample contributes an equal amount of cells into the 
clustering analysis. This could be done by sampling an equal number of cells from each sample. However, there 
are two main drawbacks of this strategy. First, a substantial amount of data (cells) may be removed from the 
analysis if there are samples with few cells, thus resulting in information loss. Second, during downsampling, 
some of the smaller populations may become under-represented or even skipped. An alternative would be to cluster 
within each sample and then aggregate a collection of metaclusters across samples46. A recent approach, called 
PAC-MAN47, uses a combination of high-dimensional density estimation, hierarchical clustering and network 
inference and comparison to extract clusters across samples, with a possibility to handle batch effects.
Additional challenges may arise when combining data from different instrument acquisitions and additional preproc-
essing treatments may need to be applied. Despite adjustments through bead-based normalization26, the observed 
marker expression may be affected by the varying efficiency of antibody binding in each batch and by the ion 
detection sensitivity after machine calibration. Beyond normalization, other strategies have been proposed, such 
as equalizing the dynamic range between batches for each marker (e.g., normalization to the 0–1 range, z-scores, 
quantile normalization), the use of warping functions to eliminate non-linear distortions (see the cydar vignette), 
landmark-based normalization48, or learning marker distribution shifts between the batches based on a manually 
gated reference cell type and using it to correct marker expression for the whole dataset9.
Alternatively, one could consider batch-wise clustering of samples. On the other hand, to be able to use those 
results, one still needs to match cell populations across batches. The matching could be done manually, or with auto-
mated approaches developed for flow cytometry46. However, a comprehensive evaluation of these approaches and 
their effect on downstream analyses is still missing. Overall, we expect that as a general rule, including batch param-
eters (or other covariates) in the linear modeling helps to mitigate the problem. In single cell RNA sequencing 
data, several methods to “align” samples have been proposed49–52 and these strategies may have applications to 
cytometry data.
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We presented a classical statistical approach where preprocessing of the HDCyto data leads to tables of summa-
ries (e.g., cell counts) or aggregated measurements (e.g., cluster-specific signals) for each sample, which become the 
input to a statistical model. Of course, there are a variety of alternative computational approaches available to the 
user. We have mentioned Citrus and CellCnn, which are both machine-learning approaches that fit a reverse 
model to ours (i.e., phenotype of interest as the response variable).
Another set of methods (MIMOSA and COMPASS), based on a Bayesian hierarchical framework, was proposed 
in the vaccine development field, where the antigen-specific T-cell response to stimulation for each subject is 
modeled using mixtures of beta-binomial or Dirichlet-multinomial distributions53,54. These strategies bear simi-
larity to the mixed models applied for differential abundance in this workflow while handling over-dispersion due 
to subject-to-subject variability.
Neither of these approaches are directly able to account for batch effects or complicated designs. However, they 
may have advantages in the search for rare distinguishing populations, which could be used together with our 
framework for formal statistical testing.
One of the main goals of this workflow was to highlight how a model-based approach is able to handle complex 
experimental designs. This becomes important in many experimental situations where covariates (e.g., age, gen-
der, batch) may affect the observed HDCyto data. Thus, the classical regression framework allows also to flexibly 
test situations well beyond two-group differences. Of course, alternatives exist for two group comparisons, such 
as the nonparametric Mann-Whitney-Wilcoxon test6, which makes no assumptions about normality of the data, 
or the Student’s t-test7 and its variations, such as the paired t-test.
We note that the LM, LMM and GLMM may perform poorly for extremely small samples. Here, solutions similar 
to those widely accepted in transcriptomics that share information over variance parameters55–57 can instead be lever-
aged. We have recently implemented methods based on these ideas in the diffcyt package13. Similarly, the cydar10 
package performs differential abundance analysis (on “hypersphere” counts) using the generalized linear 
modeling capabilities of edgeR11. For a detailed explanation and comparison of these alternative approaches, see 13.
In the differential marker expression analysis, we compare the median marker expression between samples. While 
in many cases this approach is sufficient to detect interesting changes, by summarizing marker expression over 
cells to a single value we ignore all the other characteristics of the expression distribution, such as bimodality, 
skewness and variance, which may be relevant in some studies. Thus, it may be interesting to extend our 
comparisons to the whole marker distributions, instead of just changes in the medians.
The approach presented in this workflow is not fully automated due to the cluster merging, annotating, and exten-
sive exploratory data analysis steps. In general, our philosophy is that fully automated analyses are to be avoided, 
but rather a battery of diagnostic checks can be designed, as we have promoted here. Cluster annotation remains 
a manual step in many other approaches as well. Recently, a tool was proposed for consistent characterization 
of cell subsets using marker enrichment modeling (MEM)58.
To keep the analysis of this workflow reproducible, one needs to define a random seed when running FlowSOM, 
t-SNE and UMAP. This is especially important in the clustering step, where the order of clusters may change 
with different seeds, and the cluster merging needs to be matched to the seed used. (Note that as mentioned at the 
start of the workflow, we also use the function RNGversion() to ensure backward compatibility with earlier 
versions of the workflow, due to changes to the default random number generation methods in R.)
Software availability
All software packages used in this workflow are publicly available from the Comprehensive R Archive 
Network (https://cran.r-project.org) or the Bioconductor project (http://bioconductor.org). The specific version 
numbers of the packages used are shown below, along with the version of the R installation.
sessionInfo()
## R version 3.6.1 (2019-07-05)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 16.04.6 LTS
##
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## Matrix products: default
## BLAS:   /usr/local/R/R-3.6.1/lib/libRblas.so
## LAPACK: /usr/local/R/R-3.6.1/lib/libRlapack.so
##
## Random number generation:
##  RNG:     Mersenne-Twister
##  Normal:  Inversion
##  Sample:  Rounding
##
## locale:
##  [1] LC_CTYPE=en_US.UTF-8       LC_NUMERIC=C
##  [3] LC_TIME=en_US.UTF-8        LC_COLLATE=en_US.UTF-8
##  [5] LC_MONETARY=en_US.UTF-8    LC_MESSAGES=en_US.UTF-8
##  [7] LC_PAPER=en_US.UTF-8       LC_NAME=C
##  [9] LC_ADDRESS=C               LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] parallel  stats4    stats     graphics  grDevices utils  datasets
## [8] methods   base
##
## other attached packages:
##  [1] HDCytoData_1.6.0           ExperimentHub_1.12.0
##  [3] AnnotationHub_2.18.0       BiocFileCache_1.10.0
##  [5] dbplyr_1.4.2               scater_1.14.1
##  [7] SingleCellExperiment_1.8.0 SummarizedExperiment_1.16.0
##  [9] DelayedArray_0.12.0        BiocParallel_1.20.0
## [11] matrixStats_0.55.0         Biobase_2.46.0
## [13] GenomicRanges_1.38.0       GenomeInfoDb_1.22.0
## [15] IRanges_2.20.0             S4Vectors_0.24.0
## [17] BiocGenerics_0.32.0        readxl_1.3.1
## [19] flowCore_1.52.0            diffcyt_1.6.0
## [21] ggplot2_3.2.1              cowplot_1.0.0
## [23] CATALYST_1.10.0            knitr_1.25
## [25] BiocStyle_2.14.0
##
## loaded via a namespace (and not attached):
##   [1] rappdirs_0.3.1                flowWorkspace_3.34.0
##   [3] R.methodsS3_1.7.1             tidyr_1.0.0
##   [5] bit64_0.9-7                   irlba_2.3.3
##   [7] multcomp_1.4-10               R.utils_2.9.0
##   [9] data.table_1.12.6             RCurl_1.95-4.12
##  [11] TH.data_1.0-10                RSQLite_2.1.2
##  [13] bit_1.1-14                    httpuv_1.5.2
##  [15] assertthat_0.2.1              viridis_0.5.1
##  [17] xfun_0.10                     hms_0.5.2
##  [19] evaluate_0.14                 promises_1.1.0
##  [21] DEoptimR_1.0-8                Rgraphviz_2.30.0
##  [23] igraph_1.2.4.1                DBI_1.0.0
##  [25] htmlwidgets_1.5.1             purrr_0.3.3
##  [27] ellipsis_0.3.0                RSpectra_0.15-0
##  [29] ks_1.11.6                     dplyr_0.8.3
##  [31] ggcyto_1.14.0                 backports_1.1.5
##  [33] RcppParallel_4.4.4            vctrs_0.2.0
##  [35] abind_1.4-5                   withr_2.1.2
##  [37] robustbase_0.93-5             mclust_5.4.5
##  [39] mnormt_1.5-5                  cluster_2.1.0
##  [41] lazyeval_0.2.2                crayon_1.3.4
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##  [43] drc_3.0-1                     ellipse_0.4.1
##  [45] edgeR_3.28.0                  pkgconfig_2.0.3
##  [47] labeling_0.3                  nlme_3.1-140
##  [49] vipor_0.4.5                   rlang_0.4.1
##  [51] lifecycle_0.1.0               sandwich_2.5-1
##  [53] rsvd_1.0.2                    cellranger_1.1.0
##  [55] graph_1.64.0                  flowClust_3.24.0
##  [57] Matrix_1.2-17                 carData_3.0-2
##  [59] boot_1.3-22                   zoo_1.8-6
##  [61] base64enc_0.1-3               beeswarm_0.2.3
##  [63] ggridges_0.5.1                GlobalOptions_0.1.1
##  [65] png_0.1-7                     viridisLite_0.3.0
##  [67] rjson_0.2.20                  bitops_1.0-6
##  [69] shinydashboard_0.7.1          R.oo_1.23.0
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Nowicka and colleagues present a detailed workflow for analyzing high dimensional cytometry data using
open source tools within the Bioconductor framework. 
The paper provides a clear path for analyzing high dimensional cytometry data, with biomarker discovery
in mind, starting from raw data, through preprocessing, population discovery, annotation, and differential
abundance analysis. 
Two particular strengths of the proposed approach are i) the decision to use expert-guided merging of cell
populations, and ii) the model-based differential abundance analysis of cell populations. 
The proposed visualization and summaries of the data make i) straightforward to follow and justify, and
adequate alternatives are provided and shown to perform equally well in instances where manual merging
of many clusters would be cumbersome. 
The modeling of cell population counts, rather than proportions, is an approach that we strongly support,
and the use of logistic regression with mixed effects is a natural approach that is probably insufficiently
appreciated by the community at large. That said, some of the methods proposed in the workflow have
been in use in the vaccine development field for some time and should be appropriately cited.
Specifically, in the section "Visual representation with tSNE", the authors promote coloring individual cells
on a tSNE map by expression level, and later still, stratifying by condition (Fig. 11). We point the authors
the article by Lin et al. ,  where a very similar approach, using bioconductor tools, is undertaken to identify
and visualize polyfunctional Ag-specific T-cells.
The discussion of existing methodological approaches to identify cytometry biomarkers associated with
outcome and the discussion of modeling cell counts in favor of modeling of proportions is important, but
1
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 outcome and the discussion of modeling cell counts in favor of modeling of proportions is important, but
should also reference existing work in the vaccine development field. Our group has done substantial
work in this area, developing count-based models for antigen-specific T-cell response to stimulation[ref-2
, the latter of which identified a novel biomarker of infection risk in an HIV clinical trial.
While these methods do not account for covariates, they are relevant to the discussion since they utilize
the Beta-binomial and Dirichlet-Multinomial distributions in a Bayesian formulation to handle
over-dispersion due to subject-to-subject variability (an alternative to mixed effects modeling), and
warrant mention here.
Some additional minor points: the citation of flowCore (p5) should reference the journal publication
describing the software , since it is available, rather than the software vignette.
Finally, note that flowCore is not used for analysis (p4),  which is this context we take to mean clustering
or gating, but rather is an infrastructure package that will read, write and transform cytometry data, as well
as defining gate objects.
The core infrastructure for actually performing data-driven gating in Bioconductor is implemented in
packages like flowWorkspace (Finak G, Jiang M, Gottardo R. flowWorkspace: Infrastructure for
representing and interacting with the gated cytometry. 2011.) and  openCyto .
The citations above should be added and updated for completeness and clarity.
Other than the above, the article is scientifically sound and the conclusions are justified by the data.
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 Is the description of the method technically sound?
Yes
Are sufficient details provided to allow replication of the method development and its use by
others?
Yes
If any results are presented, are all the source data underlying the results available to ensure full
reproducibility?
Yes
Are the conclusions about the method and its performance adequately supported by the
findings presented in the article?
Yes
 No competing interests were disclosed.Competing Interests:
We confirm that we have read this submission and believe that we have an appropriate level of
expertise to confirm that it is of an acceptable scientific standard.
Author Response 31 Oct 2017
, University of Zurich, Zurich, SwitzerlandMark Robinson
Thank you for taking the time to read and review our paper. Following the suggestion of the
reviewer, we have incorporated the missing references, including the reference to Lin et al. [1] in
the "Visual representation with tSNE" section, and references to MIMOSA [2] and COMPASS [3]
methods in the "Discussion" section. We have also fixed references in the "Data preprocessing"
section, including the reference to the flowCore package [4]. We have clarified that the packages
that can be used for cell gating are flowWorkspace [5] and openCyto [6].
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   Aaron T. L. Lun
CRUK (Cancer Research UK) Cambridge Institute, University of Cambridge, Cambridge, UK
 John C. Marioni
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Nowicka et al. describe a comprehensive workflow for a multi-sample analysis of a mass cytometry data
set. They provide methods and guidelines for data processing and quality control, clustering and
interpretation/visualization of the clusters. They also describe the application of statistical methods for
differential analyses within clusters. The article is clear and well-written, with some opportunities for
improvement that we have listed below. Overall, this will be useful resource for people looking to use
R/Bioconductor for cytometry data analysis.
MAJOR COMMENTS:
The principle of pooling samples prior to clustering is important to ensure that the clustering is blind
to the sample labels, and thus does not bias the downstream statistical inferences. However, in
data sets where the number of cells is highly variable across samples, larger samples may drive
the final clustering result. The authors may consider downweighting cells from larger samples
during the clustering procedure, to ensure that each sample contributes equally to the outcome.
 
In what scenarios is the NRS useful? In a mass cytometry experiment, the panel is explicitly
designed to interrogate markers of interest, so outside of quality control it makes little sense to
discard them in the analysis. Indeed, low variance contributions in PCA does not mean that the
marker is not relevant, e.g., if it marks a small population.
 
If the expected number of cell types is not known in advance, how many metaclusters should be
chosen? In very heterogeneous populations, it is easy to imagine that there may well be more than
20 distinct cell subpopulations.
 
In the discussion, the authors state that "Overall, we expect that as a general rule, including batch
1
2
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In the discussion, the authors state that "Overall, we expect that as a general rule, including batch
parameters (or other covariates) in the linear modeling largely mitigates the problem." This is true
to some extent, but will not protect the clustering from batch effects. If the batch effect shifts the
intensity distribution between batches, it is possible that a subpopulation in samples of one batch is
clustered with the wrong subpopulation in samples of another batch. The counts or median
intensities of the cluster are inherently compromised and cannot be fixed by blocking on the batch
effect in the model. In other words; when testing for changes in abundance in mass cytometry, the
cells are analogous to individual reads in a transcriptomics experiment, while the vector of
intensities is analogous to the genic region in which reads are counted. If the batch effect is
affecting the intensities, it is analogous to changes in the definition of the genes between batches.
 
The authors mention using observation weights to describe the uncertainty of the median
intensities when testing for differential expression of markers. We note that we have also used this
approach in cydar, and it seems to work well. For differential expression of markers within each
cluster, the differences in size between clusters are largely irrelevant - all else being equal, if
clusters are small, the medians should be more variable, and this should be considered by the
inference machinery when computing p-values.
MINOR COMMENTS:
A mention should be made of the fact that fsApply combines the intensity matrices from all data
sets; this was not obvious from the code.
 
There are many ways to do hypothesis testing in GLMMs, with options ranging from Wald Z-tests,
LRTs and parametric bootstrapping/MCMC. Some words on what glht actually does would be
useful.
 
Some of the figure captions could be explained in more detail. For example, the numbers and
colouring of the entries of the heatmap in Figure 4 are presumably the median marker intensities,
but this should be explicitly stated.
 
Some minor typographical errors: " (Angerer et al., 2016))", "use the flowCore [package]."
 
The PBMC data set is described as "12 different stimulation conditions", but presumably only one
was actually used (BCR/FcR-XL). This could be clarified.
Is the rationale for developing the new method (or application) clearly explained?
Yes
Is the description of the method technically sound?
Yes
Are sufficient details provided to allow replication of the method development and its use by
others?
Yes
If any results are presented, are all the source data underlying the results available to ensure full
reproducibility?
Yes
Are the conclusions about the method and its performance adequately supported by the
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Are the conclusions about the method and its performance adequately supported by the
findings presented in the article?
Yes
 No competing interests were disclosed.Competing Interests:
We confirm that we have read this submission and believe that we have an appropriate level of
expertise to confirm that it is of an acceptable scientific standard.
Author Response 31 Oct 2017
, University of Zurich, Zurich, SwitzerlandMark Robinson
Thank you for taking the time to read and review our paper.
MAJOR POINTS:
As far as we understand, downweighting of cells (e.g., from larger samples) is not currently
possible with FlowSOM. We think that, in general, it may be difficult to incorporate down-
weighting into existing clustering algorithms that are tailored for cytometry data, but indeed it
is worth considering.
One of the easy solutions to ensure that each sample contributes equally to the outcome
could be down-sampling so that equal amount of cells from each sample is used in
clustering. However, there are two main drawbacks of this strategy. First, a substantial
amount of data (cells) may be removed from the analysis resulting in information loss.
Second, during down-sampling, some of the rarer populations may become
underrepresented or even skipped. Overall, it is also hard to know exactly what "drive the
clustering" really means. We highlight these issues now in the "Discussion" section.
NRS can be used to define new panels as it was done in Levine et al. [1]. Indeed, when
there is no need for redefining the panel, it can be used as a quality control step. We
mention that now in the "Marker ranking based on the non-redundancy score" section.
In Levine et al., the NRS score was used to identify a set of surface markers that is
"sufficient" to detect the main clusters in the AML data. As the number of markers that can
be measured is limited, they could use only 16 channels for surface markers, while the
remaining 15 channels were used for signaling markers. Based on average NRS, they
identified the 16 surface markers, among 42, that explained the highest amount of variance
in their data. The final set was slightly redefined (two markers with high scores were
excluded and two markers with low scores were included) based on the biological
knowledge, which agrees with the reviewer’ statement that low variance contributions in
PCA do not mean that the marker is not relevant and vice versa. However, we think that
NRS can still serve as a relevant guide in marker selection. The final set was then used in
the panels in the following experiments.
In general, as rule of thumb, we would suggest setting the number of consensus clusters
(parameter maxK in ConsensusClusterPlus) to at least twice the number of expected cell
populations. As this number increases, it is necessary to also increase the size of the grid in
the SOM step (parameters xdim and ydim in BuildSOM).  It is not necessary to know the
exact number of cell types but rather the upper boundary for this number and treat that as
the expected number. We also propose a strategy of re-clustering, where first main cell
types are identified and extracted and then reclustered in a secondary analysis.  In the
updated version of our workflow, we have also added a section called "Obtaining higher
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updated version of our workflow, we have also added a section called "Obtaining higher
resolution" where we describe solutions using a higher amount of clusters for higher
resolution.
Yes, we fully agree that including batch effects into the linear modeling does not fully protect
the clustering from the batch effect. That is why it is important to account for batches already
at the clustering step if possible, although this is itself still a rather open (methodological
research) question. Current approaches rely on, for example, equalizing the dynamic range
between batches for each marker (e.g. normalization to the 0-1 range, z-scores, quantile
normalization), the use of warping functions to eliminate non-linear distortions (cydar [2]), or
learning marker distribution shifts between the batches based on a manually gated
reference cell type and using it to correct marker expression for the whole dataset (CellCnn
[3]). A recent method called MASC [4] that, similarly to our workflow, employs mixed models
for the differential abundance analysis deals with batches by identifying and excluding from
the clustering analysis markers with high between-batch variability and poorly recorded
cells, such as cells with extreme expression values. One could also consider, batch-wise
clustering and aggregation, but these strategies also require further study. However, the
effectiveness of these approaches has not been sufficiently studied, yet. We still
recommend including batch information in the differential analysis as it may further help to
mitigate the problem.
Indeed, we agree that the size of clusters should be built into in the inference. This happens
automatically in the differential abundance analysis, since we use (over-dispersed) logistic
regression. In the differential marker expression analysis, where the medians are compared,
one could account for the variability of medians calculated over clusters by assigning lower
weights to clusters with lower cell counts. We have not done this in the current workflow, as
we are still assessing the effect of it on the power and error control of the methods.
MINOR POINTS:
We now mention that the fsApply function, by default, combines intensity matrices from all
data sets.
We have now added some text explaining that the glht function uses t-tests to test the
hypothesis.
We have now updated the figure captions, especially those that correspond to Figures 4, 6,
7, 8, 14, 28, 30, and 32.
We have fixed the identified typos.
We have updated the description of the PBMC dataset.
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Comments on this article
Version 3
Reader Comment 04 Oct 2019
, National Institutes of Health, Bethesda, USARohit Farmer
I have made the code mentioned in this paper ready to use with the additional code to save the figures,
data structures, and TSV files. The code in my implementation can be run either interactively in
Rstudio/Nvim-R or through Rscript. I have also compiled a singularity container with all the necessary
packages for this workflow. All the scripts are also tested on a cluster with "qsub". Please find the scripts
and the documentation at https://github.com/rohitfarmer/cytof-workflow-v3
 No competing interests were disclosed.Competing Interests:
The benefits of publishing with F1000Research:
Your article is published within days, with no editorial bias
You can publish traditional articles, null/negative results, case reports, data notes and more
The peer review process is transparent and collaborative
Your article is indexed in PubMed after passing peer review
Dedicated customer support at every stage
For pre-submission enquiries, contact   research@f1000.com
Page 55 of 55
F1000Research 2019, 6:748 Last updated: 15 JAN 2020
